The Effects of a Heel Lift on Gait Parameters during Ambulation for People with Hemipareses by Avery, Bryan et al.
University of North Dakota
UND Scholarly Commons
Physical Therapy Scholarly Projects Department of Physical Therapy
2008
The Effects of a Heel Lift on Gait Parameters during
Ambulation for People with Hemipareses
Bryan Avery
University of North Dakota
Lindsay Riley
University of North Dakota
Shannon Webster
University of North Dakota
Follow this and additional works at: https://commons.und.edu/pt-grad
Part of the Physical Therapy Commons
This Scholarly Project is brought to you for free and open access by the Department of Physical Therapy at UND Scholarly Commons. It has been
accepted for inclusion in Physical Therapy Scholarly Projects by an authorized administrator of UND Scholarly Commons. For more information,
please contact zeineb.yousif@library.und.edu.
Recommended Citation
Avery, Bryan; Riley, Lindsay; and Webster, Shannon, "The Effects of a Heel Lift on Gait Parameters during Ambulation for People with
Hemipareses" (2008). Physical Therapy Scholarly Projects. 26.
https://commons.und.edu/pt-grad/26
THE EFFECTS OF A HEEL LIFT ON GAIT PARAMETERS DURING 
AMBULATION FOR PEOPLE WITH HEMIPARESIS 
by 
Bryan Avery 
Bachelor of Science in Physical Therapy 
University of North Dakota, 2006 
Lindsay Riley 
Bachelor of Arts in Biology 
Concordia College, 2005 
Shannon Webster 
Bachelor of Arts in Biology 
Bemidji State University, 2005 
A Scholarly Project 
Submitted to the Graduate Faculty 
of the 
University of North Dakota 
in partial fulfillment of the requirements 
for the degree of 
Doctor of Physical Therapy 
Grand Forks, North Dakota 
May 
2008 
This scholarly project, submitted by Bryan Avery, Lindsay Riley, and 
Shannon Webster in partial fulfillment of the requirements for the Degree of 
Doctor of Physical Therapy from the University of North Dakota, has been read 
by the Faculty Advisor under whom the work has been done and is hereby 
approved. 
~L])wfL 
Graduate AdVisor 
CAairperson 
ii 
Title 
Department 
Degree 
PERMISSION 
The Effects of a Heel Lift on Gait Parameters During Ambulation 
for People with Hemiparesis 
Physical Therapy 
Doctor of Physical Therapy 
In presenting this scholarly project in partial fulfillment of the requirements 
for a graduate degree from the University of North Dakota, we agree that the 
library of this University shall make it freely available for inspection. We further 
agree that permission for extensive copying for scholarly purposes may be 
granted by the professor who supervised our scholarly project orLin her apsence, 
by the chairperson of the department or the dean of the 'Graduate School. 'It is 
understood that any copying or publication or other use of this scholarly project 
or part thereof for financial gain shall not be allowed without our written 
permission. It is also understood that due recognition shall be given to us and to 
the University of North Dakota in any scholarly use which may be made of any 
material in our scholarly project. 
Signature /~-= ~== c=S> 
.. 
Date 0/19' ~7 
iii 
TABLE OF CONTENTS 
LIST OF FIGURES vi 
LIST OF TABLES ............................................ viii 
ACKNOWLEDGMENTS ....................................... ix 
ABSTRACT 
CHAPTER 
II 
III 
x 
INTRODUCTION ................................. 1 
Problem Statement/Purpose of Study .............. 1 
Significance of the Study ....................... . 
LITERATURE REVIEW ........................... . 
METHODOLOGY ................................ . 
1 
3 
9 
Subjects .......................... . .......... 9 
Instrumentation ............................... 11 
Procedure ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 
Data Analysis ......................... . ....... 17 
IV RESULTS AND DISCUSSION ....................... 18 
Case Study 1 
Case Study 2 
Case Study 3 
Case Study 4 
iv 
18 
23 
29 
34 
TABLE OF CONTENTS (Cont.) 
Case Study 5 ................................. 41 
V SUMMARY AND CONCLUSION ..................... 47 
Limitations/Recommendation of Study . . . . . . . . . . . . . . 48 
Clinical Implications ............................ 51 
Conclusion ................................... 52 
APPENDICES 
A IRB Form 
B Consent Form .................................. . 
C Medical Questionnaire ............................ . 
D Data Collection Form ............................. . 
E GAITRite© Footfall Patterns ........................ . 
F DVD of Subjects Walking ......................... . 
REFERENCES ............................................. . 
v 
53 
63 
66 
68 
70 
81 
83 
LIST OF FIGURES 
Figure Page 
1 Size width comparison of the 9.5 mm heel lift to a Bic© pen 13 
2 Top view of the medium-sized 9.5 mm heel lift used in 
the study .................. . ...................... . 13 
3 The subject's feet are being centered on the Balance 
Maste~ ... . ...................................... . 14 
4 The subject's ankle dorsiflexion is being measured with a 
goniometer ....................................... . 15 
5 The subject is getting instructions before walking down the 
GaitRite© ......................................... . 16 
6A Subject 1 has just finished walking down the GaitRite© ..... . 19 
6B Velocity - Subject 1 ...... . .......................... . 20 
6C Step Length - Subject 1 20 
60 Single Limb Support - Subject 1 ....................... . 21 
6E Swing Time Percentage - Subject 1 .................... . 22 
7A Subject 2 just completed a walk down the GAITRite© ....... . 24 
7B Velocity - Subject 2 ................................. . 25 
7C Step Length - Subject 2 ............................. . 26 
70 Single Limb Support - Subject 2 ....................... . 26 
7E Swing Time Percentage - Subject 2 .................... . 27 
8A Subject 3 has just finished walking down the GAITRite© 30 
vi 
LIST OF FIGURES (Cont.) 
Figure Page 
8B Velocity - Subject 3 .................................. 31 
8C Step Length - Subject 3 . .......... . .................. 31 
8D Single Limb Support - Subject 3 . ....................... 32 
8E Swing Time Percentage - Subject 3 ..................... 33 
9A Subject 4 completing a walk across the GAITRite© . . . . . . . . . . 35 
9B Velocity - Subject 4 .................................. 36 
9C Step Length - Subject 4 ... . .............. ... ......... 38 
9D Single Limb Support - Subject 4 ........................ 38 
9E Swing Time Percentage - Subject 4 ..................... 39 
10A Subject 5 completing a walk across the GAITRite© . . . . . . . . . . 42 
1 DB Velocity - Subject 5 .................................. 42 
1 DC Step Length - Subject 5 .............................. 43 
10D Single Limb Support - Subject 5 ........................ 44 
1 DE Swing Time Percentage - Subject 5 .. . ........ ... ....... 44 
vii 
LIST OF TABLES 
Table Page 
1 Subject Demographics ................. . .............. 10 
2 Lower Extremity Weight Bearing Percentages Using the 
Balance Master® .................................... 14 
3 Subject Four Left Step Length Results .................... 37 
viii 
ACKNOWLEDGMENTS 
We would like to thank Meridee Green-Danks, DPT, NCS, for the 
extensive time and effort put forth to make this study happen. Her hard work 
and encouragement challenged us and made us think more in-depth about how 
we presented the material in this study. Special thanks to Dave Reiling, Renee 
Mabey, and Alyson White for their expertise and willingness to help. We would 
also like to thank the whole UND Department of Physical Therapy staff for 
providing us with extensive knowledge through the past three years to help us 
get ready for entry-level practice. Thanks to our families for all the support and 
patience over the past three years for helping us get through this program so we 
an have successful careers in the field of physical therapy. 
Bryan Avery, Lindsay Riley, Shannon Webster 
ix 
ABSTRACT 
People with hemiparesis can have difficulty weight-bearing through their 
involved lower extremity. This can lead to asymmetry during static standing and 
dynamic activities including gait. Previous research has shown improved 
symmetry in static standing when a heel lift is inserted under the non-paretic 
lower extremity. The purpose of this study is to determine if a heel lift can 
improve symmetry during dynamic gait in people with hemiparesis. 
Five subjects (1 female, 4 male) with unilateral hemiparesis were recruited 
from the community. All demonstrated greater than 55% of weight-bearing on 
the non-paretic limb in static standing. Hemiparesis resulted from either a stroke 
or a brain tumor. Gait parameters were measured using the GAITRite® walkway 
system. Subjects ambulated a minimum of 20 steps both with and without a 9.5 
mm heel lift inserted. Gait velocity, step length, single limb support time, and 
swing time were analyzed for each test condition. 
Subjects could not be compared due to the variation between them. A 
series of five case stUdies are presented based on individual findings as 
measured by percent change. A heel lift under the non-paretic limb showed 
greater weight shifting onto the paretic limb for one subject. Improved gait 
velocity and symmetry in step length were noted for this subject. Another subject 
subjectively reported that the heel lift insert made ambulation easier for him, 
x 
even though analysis of the gait parameters showed little change in his gait 
symmetry. Use of the heel lift successfully improved gait symmetry in one 
subject and was subjectively beneficial to another subject. No definite 
conclusion can be made overall, but it does appear that use of a 9.5 mm heel lift 
may improve weight -bearing onto the paretic lower extremity and subsequently 
lead to greater symmetry during dynamic gait activities in certain subjects with 
hemiparesis. 
xi 
CHAPTER I 
INTRODUCTION 
People with hemiparesis often have problems with putting weight through 
their involved extremity. This may be a confidence issue or a learned response 
during the rehabilitation period after the incident. People with hemiparesis have 
weakness, sensation, and proprioception deficits and may have spatial relation 
syndrome on their affected side. 1 
Problem Statement/Purpose of Study 
People with hemiparesis may have asymmetry during static and dynamic 
activities that may diminish their function and abilities. The purpose of this 
research study is to determine the effect a heel lift has when it is inserted in the 
uninvolved shoe of a person with hemiparesis. The research questions for this 
study are: 
1. Does wearing a heel lift on the uninvolved side improve ambulation for 
people with hemiparesis? 
2. Does wearing a heel lift improve symmetry of gait? 
Significance of the Study 
Previous research has shown that a heel lift inserted under the uninvolved 
side improves weight-bearing symmetry in static balance for individuals with 
hemiparesis.2-4 Individuals with hemiparesis can have a deficit in symmetry to 
1 
2 
the involved side during dynamic activities, such as gait, and they may have 
diminished function if an asymmetry is present. Currently, there is little research 
describing the effects of a heel lift involving dynamic walking with this patient 
population. 
CHAPTER II 
LITERATURE REVIEW 
The central nervous system (CNS) controls and regulates all mental and 
physical functions. 1 Disease or trauma of the CNS may cause damage to 
several types of tissues in a local area, or it may cause dysfunction in one type of 
tissue throughout many areas of the CNS. Damage to cells to a local point in the 
brain can result in hemiplegia. Hemiplegia is the paralysis of one side of the 
body from damage to the corticospinal tracts of the CNS.5 The most common 
cause of hemiplegia is from a stroke caused by a thrombosis, brain hemorrhage, 
or cerebral embolism. Tumors can also be responsible for hemiplegia but are 
less common. With such an injury to the brain tissue, hemiparesis contributes to 
impairments in balance, walking difficulties, and increase risk of falls. 6 
There have been consistent gait differences that have been found with 
individuals who have hemiparesis. Gait in individuals with post-stroke 
hemiparesis is characterized by reduced speed, cadence, stride length, 
increased step width, and asymmetrical step length .7 Gait differences found in 
post-stroke hemiparesis include impaired swing initiation of the paretic limb, 
inadequate propulsion of the leg during pre-swing, increased percentage swing 
time, reduced knee flexion at toe-off, shortened limb support on the paretic limb, 
and exaggerated propulsion of the non-paretic limb during pre-swing. 
3 
4 
Hemiparetic gait is also affected by compensatory strategies and motor 
behaviors that include pelvic hiking and wing-phase propulsion along with 
circumduction of the paretic limb. All of these deviations in gait increase energy 
use during ambulation which can cause fatigue in the individual. According to 
Bohannon,8 the major deviations noted for asymmetry of gait are appearance, 
temporal measures, and distance measures. Temporal asymmetry includes 
relative time spent on the involved versus uninvolved limb as measured in 
percent of total gait cycle. A commonality noted for people with hemiparesis is 
increased time spent on the uninvolved limb during stance phase of gait. 
Distance asymmetry from hemiparesis results in a decrease in stride 
length. Step length is a more reliable determinant of gait since stride length is 
not as sensitive to change. Step length is highly correlated with temporal 
parameters such as gait velocity, double limb support time, and stance time.8 
Standing balance of individuals with hemiparesis is characterized by 
increase postural sway and by a shift in the average position of the center of 
pressure toward the uninvolved limb during static standing.9•1o People without 
hemiparesis have relatively equal weight-bearing when the feet are parallel in the 
same place. With the feet positioned astride, tests revealed deficiencies in 
shifting weight posterior laterally over both the affected and non-affected legs 
with hemiparetic individuals. There was more of a deficiency toward the affected 
leg in diagonal position. All of the weight shifting limitations discussed were 
significantly below the values for normal individuals without hemiparesis. 
5 
Walking aids have been introduced to people with hemiparesis to try to 
reduce the postural sway. Walking aids have been proven to increase postural 
stability, improve muscle action, and to reduce the load on the involved weight-
bearing leg.9 After a eNS lesion occurs that results in hemiparesis, people will 
often times use a walking aid, such as a standard cane or quad cane, to 
increase their walking ability. Giving a walking aid, like a cane, can encourage 
people with hemiparesis to walk with a more normal gait pattern. The use of a 
cane does not improve the asymmetrical weight-bearing pattern during stance 
that is a characteristic of people. 
Physical therapy has looked at improving gait patterns by using an ankle 
foot orthosis (AFO) on patients with hemiparesis. According to Pohl et al,6 the 
AFO can improve spatio-temporal parameters of gait and lower the energy costs 
of walking. The use of an in-shoe AFO improved weight-bearing on the paretic 
leg and improved postural sway in stance. Wang et al 11 reported that weight 
bearing was more evenly distributed when the subject wore the AFO on the 
paretic leg. The AFO works by providing ankle stability by keeping the ankle joint 
in a good alignment and giving external support. Subjects with hemiparesis of 
less than six months duration found that the AFO improved the symmetry in quiet 
standing and the dynamic standing balance as measured by the Balance 
Master®. The AFO also improves gait speed and cadence with an onset of less 
than six months. Subjects that were greater than 12 months post-incident did 
not have as good results on balance and gait with AFO use. 
6 
Extensive research has been conducted to determine effective treatments 
for individuals with hemiparesis. This is due to the fact that hemiparesis, with its 
potential for significant weakness and sensation deficits, can alter functional gait 
parameters as well as other weight-bearing activities related to balance. The 
majority of research has been in the area of static balance symmetry.2-4 
Individuals experiencing unilateral hemiparesis can develop misuse of the 
involved limb if there is a weight-bearing asymmetry present.2,3 There is 
evidence supporting forced-use interventions as well as programs designed to 
re-train the involved limb for improved gait parameters, including but not limited 
to the Bobath method, harness lifts, and treadmill training.3 
The use of a heel lift or shoe wedge under the uninvolved limb in 
individuals with hemiparesis has also been demonstrated to be an effective 
intervention to improve weight-bearing asymmetry in stance.2-4 It is believed that 
increasing the length of the uninvolved limb forces the body to shift weight onto 
the involved limb and in effect provide input and force the use of the limb. 
Different types of shoe lifts or wedges have been used to test this theory. 
Chaudhuri et al4 demonstrated improved weight-bearing symmetry with 
the use of a 6 mm and 9 mm shoe lift. Subjects were measured using the 
NeuroCom Balance Master-Equitest device for both symmetry and dynamic 
balance perturbations. Two of the subjects wore an AFO but no other assistive 
device was used. Each of the ten subjects was within the range of 2.3 to 22.1 
weeks post-stroke at the time of the study. They all had resultant unilateral 
hemiparesis. The researchers found that use of either the 6 mm or 9 mm shoe 
7 
lifts approached near 50/50 weight-bearing on the involved and uninvolved 
hemiparetic limbs. They concluded that shifting weight to the involved limb with 
the shoe lift leads to greater control through muscle activity stimulation. 
Rodriguez et al3 investigated the effects of a shoe lift as well as a shoe 
wedge on weight-bearing symmetry. Nine subjects with unilateral hemiparesis 
that were 2 to 8 weeks post-stroke were assessed in static standing using the 
Balance Master to determine weight-bearing ratios. In order to meet inclusion 
criteria, the subjects had to stand independently without an AFO or other 
assistive device for 5 minutes. The most effective intervention (closest to 50/50 
ratio) was the 5 ° shoe wedge. The 12 mm shoe lift was the most effective height 
for its category. The use of a 12.5° shoe wedge showed reversed weight-
bearing asymmetry where there was a greater weight-bearing on the involved 
limb. Both the shoe lift and wedge showed carryover of symmetry gains towards 
the involved limb when the subjects' final measurement was taken without any 
shoe insert. Although the wedge showed the greatest effect, there was concern 
that it increased the potential for injury since it promoted foot eversion. However, 
the researchers concluded that up to a 7° shoe wedge angle could be safe for 
clinical use. 
Ariun et al2 tested a shoe lift in individuals with unilateral hemiparesis that 
presented with diminished weight-bearing on the involved lower extremity. All 
eight of the subjects had a stroke resulting in hemiparesis 0.16 to 5 years prior to 
the study. Five of the subjects wore an AFO. There was no mention if the 
added height of the ankle-foot orthosis was taken into account when applying the 
8 
heel lift to the non-involved limb. Subjects' weight-bearing was assessed using 
the Balance Master in static standing, but the article did not specify what weight-
bearing test was used. The results showed an almost 50/50 weight-bearing ratio 
with a 10 mm shoe lift. One of the subjects was given a 10 mm shoe lift to use 
while completing a six-week physical therapy program as well as during any daily 
leisure activities. The subject was assessed wearing the shoe lift while 
ambulating on a 10 meter walkway with optoelectronic sensors to determine 
velocity and the step print technique to measure stride length. The Balance 
Master® weight-bearing test was used to determine static standing symmetry. 
Results under these conditions showed improved weight-bearing symmetry 4 
days after completing the program. Carryover of symmetry was seen even after 
10 weeks without using the shoe lift, although it was not as high as the 
measurement taken 4 days post-completion. In addition, the subject's gait was 
assessed with improvements shown in gait velocity and stride length after 
completion of the therapy program. Gait velocity has been shown to be a valid 
determinant of hemiparesis functional recovery. Fugl-Meyer Lower Extremity 
Assessment and Balance Scale post-test scores showed improvement 
compared to pre-test. Aruin et al2 concluded that shoe lifts would be beneficial in 
balance re-training programs for individuals with hemiparesis. 
CHAPTER III 
METHODOLOGY 
The research design was reviewed and approved by the UND Institutional 
Review Board (Approval #IRB-200704-325). (See Appendix A.) Subjects read 
and signed an approved consent form (Appendix B) prior to beginning the study 
and were given a copy of this form. A copy of the approved medical 
questionnaire (Appendix C) and subject data collection form (Appendix D) are 
provided. 
Subjects 
Five subjects (1 female, 4 male) were included in the study with a mean 
age of 68 ± 11.47 years (range of 52 to 79 years). Two subjects had left 
hemiparesis and 3 subjects had right hemiparesis. One subject's hemiparesis 
was the result of a post-brain tumor resection, while the 4 other subjects had 
post-stroke hemiparesis. Time since hemiparetic incident ranged from 2 years to 
11 years. Subjects in this study were recruited from the community (Table 1). 
Subjects completed a medical questionnaire to screen for any serious 
medical conditions that may limit full participation in the study. This included 
other neurological disorders, unstable medical conditions, severe visual or 
vestibular deficits, recent trauma, or other orthopedic problems directly affecting 
balance and ability to ambulate. Inclusion criteria included a diagnosis of left or 
9 
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Table 1. Subject Demographics 
Hemiparesis Time Since Assistive 
Subject Age Gender (L or R) Lesion Incident AFO Use Device 
1 79 Female Left Stroke 11 years Left Cane 
(SPC) 
2 52 Male Left Brain 2 years Left Cane 
Tumor (SPC) 
3 75 Male Right Stroke 6 years None Cane 
(SPC) 
4 60 Male Right Stroke 2.5 years Right None 
5 74 Male Right Stroke 2 years None None 
SPC = single point cane 
right hemiparesis, having this diagnosis for 6 or more months, and age 18 years 
or older, ability to be able to follow two-step directions, walk independently for at 
least 50 feet with or without an assistive device, have an asymmetric static 
posture exhibiting more than 55% of body weight dispersed on the uninvolved 
limb as shown on the Balance Master, and own laced shoes that do not have 
more than a half-inch heel. 
Assessment included gait analysis both with and without the heel lift 
insert. Randomization was completed by having the subjects pick a card 
designating no heel lift during the first trial; if the second card was chosen, the 
subject would walk with the heel lift during the first trial. Gait analysis was 
performed under the first randomized condition and repeated with the other 
condition. 
11 
I nstru mentation 
The Balance Maste~(NeuroCom International, Inc., Clackamas, Ore.) 
was used to obtain static standing weight-bearing ratios. This instrument is 
designed to assess and treat balance deficits. The system uses dual force 
plates to analyze the vertical forces exerted on it, and a computer output can be 
generated. 12 The assessment completed was the Weight-Bearing Squat (WBS) 
test with 0° knee flexion. Liston et al13 demonstrated that the Balance Maste~ 
had good test-retest reliability among patients with stroke. 
The GAITRite® (CIR Systems, Inc., Havertown, Pa.) was used to measure 
the spatial and temporal parameters of gait. This instrument is an electronic 
walkway that is connected to a PC that analyzes an individual's gait. The 
walkway is 16 ft. long x 3 ft. wide and has 18 432 pressure-sensitive sensors that 
determine data. It has been proven to be a valid and reliable tool for assessing 
gait parameters in both a normal population as well as populations that have 
dysfunction .14-16 
Webster et al14 compared the GAITRite® walkway system to the Vicon 5-
12®, a three-dimensional motion analysis device. This study compared the 
validity of the spatial and temporal aspects of gait between the two systems. 
The subjects wore the Vicon 5-12® system as they walked down the GAITRite® 
walkway. This allowed for simultaneous data collection from both systems. Both 
systems looked at velocity, cadence, step length, and step time during the same 
walking trial. Paired t-tests revealed that there was excellent agreement 
between the two systems. 
12 
McDonough et al15 tested one healthy woman subject with video analysis 
while walking on a GAITRite® and simultaneously walking on paper placed over 
the talking surface. This allowed for comparison of three methods of 
measurement at the same time. This article also supported the validity of the 
GAITRite® walkway system when looking at gait parameters. 
Bilney et al 16 compared the GAITRite® system to the Clinical Stride 
Analyze~. The study looked at the concurrent validity as well as the test-retest 
reliability of the GAITRite® system. The results found good concurrent validity 
between the systems. Uden et al17 also assessed the test-retest reliability of the 
GAITRite® walkway system on subjects initially and then a week later to see if 
the same results would be achieved. The GAITRite® walkway system proved to 
be very reliable for test-retest reliability a week apart. 
A pilot study was completed with the use of both the GAITRite® and 
Balance Maste~ Weight-Bearing Squat test. The testers of this study were 
trained in the use of the equipment and demonstrated intra-rater reliability in all 
measurements prior to the start of the study. 
Three Adjust-a-lift (UCOheal®, Wheeling, III.) heel lifts, size small, 
medium, and large, were used. These rubber lifts are adjustable height from 9.5 
mm to 6.4 mm to 3.2 mm. For the purpose of this study, the 9.5 mm height was 
used. (See Figures 1 and 2.) 
Procedure 
The Balance Maste~ was set-up before the subject data collection 
process. After completion of the medical questionnaire and signature of 
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Figure 1. Size width comparison of the 9.5 mm heel lift to a Bic© pen. 
Figure 2. Top view of the medium-sized 9.5 mm heel lift used in the study. 
informed consent, subject eligibility was determined. Subjects' height was 
measured in feet and inches with shoes on and input into the Balance Maste~. 
Subjects stood with both feet within the blue marked box on the force plates 
(Figure 4). They were then asked to march in place three times and then stand 
comfortably while the weight-bearing ratio measurement was recorded. Weight-
bearing ratio left to right was measured in three trials and averaged. See Table 
2. 
Table 2. Lower Extremity Weight-bearing Percentages Using the Balance 
Master® 
'-
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Figure 3. The subject's feet are being centered on the Balance Maste~. 
Table 2. Lower Extremity Weight-bearing Percentages Using the Balance 
Maste~ 
Trial 1 Trial 2 Trial 3 Average of 3 Trials 
Left Right Left Right Left Right Left Right 
Subject 
1 46 54 38 62 38 62 40.7 59.3 
Subject 
2 53 47 30 70 40 60 42.8 57.2 
Subject 
3 73 27 78 22 81 19 77.3 22.7 
Subject 
4 77 23 75 25 68 32 73.3 26.7 
Subject 
5 62 38 59 41 60 40 60.3 39.6 
Baseline measurements for light touch sensation were performed in sitting 
and following the dermatome patterns for Ls through S2 nerve roots. Sensation 
15 
was recorded as absent, diminished, or normal for both the right and left lower 
extremities. Active ankle dorsiflexion range of motion was measured in sitting 
with knees bent with a goniometer and documented for both left and right ankle 
(Figure 4). Leg length measurements were taken from the top of the greater 
trochanter to the floor through the lateral malleolus and with shoes on. Leg 
length was documented in centimeters to input into the GAITRite® computer 
program. Leg length was required to calculate gait parameters. 
Figure 4. The subject's ankle dorsiflexion is being measured with a goniometer. 
Randomization was completed following baseline measurements. As 
subjects were randomized, the researchers inspected the subjects shoes to 
verify heel height and whether a heel lift could be properly inserted. 
The GAITRite® was set up in the Department of Physical Therapy. Two 
large Xs of tape were placed on opposite walls to remind the subjects to keep 
their heads up during testing. On both ends of the GAITRite®, an additional 6-
foot walking distance was marked with a tape line on the floor. This was to 
ensure that the subjects did not improperly accelerate or decelerate as they 
, 
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walked on the instrument. With the additional walking distance, the total length 
of the walkway was 28 feet (Figure 5). 
Figure 5. The subject is getting instructions before walking down the GAITRite©. 
After data collection, subjects provided written consent to be videotaped 
while ambulating on the GAITRite®. The patients were instructed to walk at a 
normal pace. Under the first randomized condition, subjects ambulated until 20 
step were obtained which equaled approximately three to four walks. Subjects 
then ambulated under the second randomized condition until 20 steps were 
obtained. Subjects were provided adequate rest time between trials as needed. 
Assistive devices or AFOs were permitted during ambulation (see Table 1). All 
of the subjects wore a gait belt during the trials and a spotter provided contact 
guard assistance while walking next to the individual. 
'-
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Data Analysis 
Due to the wide variation of the subject demographics, statistical analysis 
was not possible on the chosen gait parameters. Results are presented in a 
series of case studies outlining individual findings comparing heel lift to no heel 
lift. Gait velocity, step length, single limb support time, and swing time were 
analyzed to determine if the subjects gait improved with the use of a heel lift on 
the non-paretic limb. 
CHAPTER IV 
RESULTS AND DISCUSSION 
The following chapter will outline the case descriptions and outcomes of 
the five subjects that participated in this study. The information provided in each 
case study will include subject history, objective measurements, data analysis, 
observational gait, and discussion. To view the GAITRite® footfall patterns of 
each case study, refer to Appendix E. For each subject, it was expected that 
using a heel lift would increase gait velocity, improve step length symmetry, 
increase single limb support time of the paretic limb, and increase swing time of 
the non-paretic limb. 
Case Study 1 
Subject 1 was a 79-year-old female, 5 feet 3% inches, who had left 
hemiparesis resulting from a stroke 11 years ago. Past medical history included 
atrial fibrillation, hypertension, and right ankle triple arthrodesis. Subject 
reported that she currently wore glasses, utilized a single point cane on the right 
and an AFO on her left foot, and was able to walk 200 meters independently. 
Activity level included independence in ADLs with no history of falls. Motivation 
level was high to try any new treatments or surgeries to decrease her 
impairments including participation in physical therapy sessions two times a 
week for several weeks. Subject reported that a heel lift was previously used to 
18 
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compensate for a leg length difference attributed to wearing an AFO. Subject 
continued to wear an AFO even after a successful ankle fusion, but no longer 
uses heel lift on non-paretic side (Figure 6A). 
Figure 6A. Subject 1 has just finished walking down the GAITRite©. 
Objective Measures 
Sensation to dermatomes L4-S2 were normal to light touch, and sitting 
active ankle dorsiflexion range of motion on the paretic limb measured 2 0 and 
non-paretic limb measured 13 0 • Leg length measurement with shoes on for the 
paretic limb was 89 centimeters and for the non-paretic limb was 90 centimeters. 
Heel height measured 2 centimeters on either shoe. Weight-bearing ratio was 
40.7% on the paretic limb and 59.3% on the non-paretic limb. 
Data Analysis 
This subject's velocity increased from 25.26 m/min to 25.86 m/min while 
wearing the 9.5 centimeter heel lift. The percent change was a 2.4% increase 
with the heel lift (Figure 68). 
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Step length on the paretic limb increased with the heel lift inserted from 41 
cm to 48.5 cm. Percent change for the paretic limb was 18.3%. Non-paretic 
step length decreased from 31.8 cm to 22.9 cm for a percent change of -28.0% 
with the heel lift insert (Figure 6C). 
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Single limb support on the paretic limb was 29.3% without the heel lift and 
decreased to 24.1 % with the heel lift. The non-paretic limb single support was 
32% without the heel lift and increased to 35.8% with the heel lift. Percent 
change for the paretic limb was -21.6% and 11.9% for the non-paretic limb with 
the heel lift (Figure 60). 
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Swing percentage of the paretic limb without a heel lift was 31.9% and 
increased to 35.9% with a heel lift. The non-paretic limb swing percentage was 
29.3% without a heel lift and decreased to 24% with the heel lift inserted. 
Percent change for the paretic limb was 12.5% and for the non-paretic limb was -
22.1 % with the heel lift inserted (Figure 6E). 
Observational Gait 
Through video observation, an asymmetry was noted with more weight-
bearing transferred through the uninvolved limb. The left arm did not swing 
during any part of the gait cycle and showed increased tone while ambulating. 
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Figure 6E. Swing Time Percentage - Subject 1 
Backward lean strategy and hip hiking on the right occurred to advance the 
involved limb. Increased tone as evident in the involved limb and limited knee 
flexion , making it difficult to advance the right leg. There was no ankle 
dorsiflexion due to the triple arthrodesis and use of an AFO on her left side. See 
Appendix F for DVD of subject walking. 
Discussion 
While reviewing the subject's data from the GAITRite®, no noticeable gait 
change in improved symmetry was observed under the testing parameters. 
Subject continued to incorporate a backward lean technique to advance the 
involved limb during swing phase. The subject did not subjectively report any 
improvements in her ability to ambulate with the 9.5 mm heel lift inserted. 
Walking velocity has been shown to be a good determinant of hemiparesis 
functional recovery.2 Velocity for this subject was well below the normal for her 
age group. The normal comfortable velocity for a healthy adult in the 70th 
'-
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decade is 76.3 m/min.18 The heel lift did increase her velocity by 0.60 m/min 
(2.4% change). Step length for the paretic limb increased with the use of the 
heel lift (18.3%) and the non-paretic limb step length decreased by 28%. It was 
expected that step length for the non-paretic limb would increase but was not the 
case for subject 1. These findings may have been due to the increased amount 
of clearance provided by the heel lift for the paretic limb. 
The normal percentage of single limb support for the reference leg for 
older adults in the total gait cycle is 40%. In comparison, the normal percentage 
of swing phase for the reference leg in the healthy older population is 30%.19 
Subject 1's single limb support and swing phase percentage findings in the gait 
cycle were consistent with the step length results. In order to have an increased 
step length on the paretic limb, more time must be spent in single limb support 
on the non-paretic limb with a longer swing phase on the paretic side. 
The participant has been living with hemiparesis for 11 years and has 
developed many strategies to compensate for her impairments. It may be 
unlikely that a single session of using a heel lift under the uninvolved limb would 
have much effect on these strategies. 
Case Study 2 
Subject 2 as a 52-year-old male, 5 feet 11 inches, with left hemiparesis 
due to a brain tumor resection 2 years ago. His past medical history included 
radiation therapy and ringing in ears. He wore a 6.5 mm heel lift for his right 
shoe from a physical therapist previously, but it was unknown how long he has 
utilized it. This heel lift was used to compensate for a leg length discrepancy 
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caused by the use of an AFO on the left ankle. The subject was currently using 
his AFO. He reported being able to ambulate 2 blocks independently with the 
use of a single point cane. Falls were common the first 15 months after brain 
surgery, but he has not fallen in the past 10 months (Figure 7 A). 
Figure 7 A. Subject 2 just completed a walk down the GAITRite©. 
Objective Measurements 
Sensation was intact for dermatomes L4-S2 to light touch. Sitting active 
ankle dorsiflexion range of motion measured 0 0 on the paretic limb and 13 0 on 
the non-paretic limb. Leg length measurement with shoes on for the paretic limb 
was 96 cm. Three different measurements of leg length were taken on the non-
paretic limb due to the subject's prior use of a heel lift. Measurements for leg 
length with shoes on was _95.5 cm without any heel lift, 98 cm with his own heel 
lift, and 99 cm with the researchers' 9.5 mm heel lift. For this study, the 
measurement of 95.5 cm as used to remain consistent with other subjects. Heel 
height measured 2.5 cm on either shoe. Weight-bearing ratio was 42.8% on the 
paretic and 57.2% on the non-paretic. For this study, the subject's own heel lift 
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was removed from his right shoe and a 9.5 mm heel lift was placed in the right 
shoe. 
Data Analysis 
Gait velocity increased from 26.76 m/min to 28.74 m/min when wearing 
the new 9.5 mm heel lift. Percent change for velocity was 7.4% with the heel lift 
(Figure 78). 
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Figure 78. Velocity - Subject 2 
With the heel lift, the step length increased on the paretic limb from 44.9 
cm to 45.5 cm for a percent change of 1.3%. Step length increased on the non-
paretic limb from 36.1 cm to 42.5 cm for a percent change of 17.7% with the heel 
lift (Figure 7C). 
Single limb support percentage for the paretic limb without a heel lift was 
24.2% and decreased to 23.8% with the addition of the heel lift insert. The non-
paretic limb single limb support was 33.2% without the heel lift and increased to 
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34.4% with a heel lift. Percent change for the paretic limb was -1.7% and for the 
non-paretic limb was 3.6% with the heel lift (Figure 70). 
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Swing phase percentage of the paretic limb without a heel lift was 32.9% 
and increased to 34.5% with a heel lift. Non-paretic limb swing phase 
percentage without a heel lift was 24.5% and decreased to 23.8% with a heel lift. 
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Percent change for the paretic limb as 4.9% and -2.9% for the non-paretic limb 
with the heel lift (Figure 7E). 
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Figure 7E. Swing Time Percentage - Subject 2 
Observational Gait 
Through video observation, subject used a hip hike and limb 
circumduction . strategy to advance his involved limb due to minimal left knee 
flexion and ankle dorsiflexion. There was an audible left foot drag with each step 
and left foot placement was supinated which forced the subject to walk on the 
latter aspect of his shoe. This was evident by the wear pattern on his shoe. This 
substitution pattern gave his ankle a varus appearance. Due to left hemiparesis 
in the upper extremity, left arm swing did not occur normally during the gait cycle. 
Refer to Appendix F for DVD of subject walking. 
Discussion 
Subject 2 was unique from the other study participants since he was the 
only subject who had unilateral hemiparesis as a result of a brain tumor 
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resection . His heel lift had been worn for an undetermined amount of time and 
showed obvious wear from use, since it measured about 3 mm less than the 9.5 
mm lift used in this study. At this time, the subject's personal heel lift was 
removed and data collection continued for this subject with no heel lift in the right 
shoe. The 9.5 mm heel lift was then inserted into the right shoe and data 
collection was completed for this condition. 
No obvious observable changes in symmetry or gait pattern were seen 
with the new heel lift under the non-paretic limb after viewing video recording. 
Swing phase compensations continued to show a slight foot drag, hip hiking, and 
lim circumduction on the paretic side. It is possible that due to his previous 
experience with a heel lift under the non-paretic limb, this subject had already 
established compensatory strategies. 
Normal comfortable velocity for a healthy adult in the 50th decade is 83.6 
m/min.18 Measured gait velocity for this subject increased by 1.98 mlmin (7.4% 
change). The use of a heel lift improved symmetrical step length to within 3 cm 
paretic compared to non-paretic. The subject was able to achieve a 6.4 cm 
greater increase in step length on the non-paretic side allowing for a more 
normalized step pattern bilaterally. 
The heel lift was expected to cause weight shifting and weight acceptance 
to the paretic limb for longer single limb support time. The heel lift insert did not 
affect single limb support percentage in this subject. Non-paretic single limb 
support remained greater compared to the paretic, but both values were below 
the normal percentage for the total gait cycle. This is common in individuals with 
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hemiparesis, since they are more stable during ambulation by limiting single limb 
support time and increasing time in double limb support. 
Swing phase findings were consistent with the single limb support results. 
Since the subject spent less time on the left leg compared to the right during 
single limb support, it was expected that swing phase would also be limited on 
the right side. Inability to properly weight shift and accept that weight on the 
involved limb led to a decrease in swing time for the uninvolved limb. 
Ambulating with the heel lift did not affect the ratio of left to right swing phase 
percent. 
Use of a heel lift insert on the uninvolved side showed improvement in 
both gait velocity and step length. Single limb support and swing phase 
percentages did not show improved symmetry. Symmetrical step length was the 
most notable change when using the heel lift. 
Case Study 3 
Subject 3 was a 76-year-old male, 4 feet 11 inches, with right hemiparesis 
from a stroke 6 years ago. His past medical history included heart disease, 
hypertension, and coronary artery bypass surgery. He currently wore glasses. 
He stated he used a single point cane within his home and a walker for 
ambulation in the community. Subject reported that he could ambulate 50 feet at 
one time. He reported no history of falls within the home or community (Figure 
SA). 
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Figure 8A. Subject 3 has just finished walking down the GAITRite©. 
Objective Measurements 
Light touch sensation to dermatomes L4-S2 were normal, and sitting active 
ankle dorsiflexion range of motion measured 10° on the non-paretic limb and 9° 
on the paretic limb. Leg length measurement with shoes on for the non-paretic 
limb was 80 cm. and for the paretic limb was 79 cm. Shoe heel height measured 
2 cm. for each shoe. Average weight-bearing ratio was 77.3% on the non-
paretic limb and 22.7% on the paretic limb which was more asymmetrical than 
the other subjects in this study. 
Data Analysis 
Velocity with this subject without the heel lift was 28.08 m/min. and with 
the heel lift decreased to 27:48 m/min. Percent change for velocity was -2.1 % 
with a heel lift (Figure 88). 
Step length increased on the paretic limb from 17.9 cm. without the heel 
lift to 18.9 cm. with the heel lift inserted. The non-paretic limb step length was 
36.2 cm. without the heel lift and decreased to 35.7 cm. with the heel lift. 
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Percent change for the paretic limb was 5.6% and for the non-paretic limb was -
1.4% with a heel lift (Figure 8e). 
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Single limb support percentage for the paretic limb without the heel lift 
inserted was 28.4% and decreased to 27.9% with the heel lift. The non-paretic 
limb single limb support was 38% without a heel lift and increased to 39.4% with 
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the heel lift. Percent change for the paretic limb was -1.8% and 3.7% for the 
non-paretic limb with a heel lift (Figure 8D). 
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Swing time percentage for the paretic limb without a heel lift insert was 
38.3% and increased to 39.7% with the heel lift. The non-paretic limb swing time 
was 28.2% without the heel lift and decreased to 27.7% with the heel lift. 
Percent change for the paretic limb in swing time was 3.7% and was -1 .8% for 
the non-paretic limb with a heel lift (Figure 8E). 
Observational Gait 
Through video observation, the subject ambulated by using a single point 
cane in the left hand. Subject had a flexed overall body posture, ambulated with 
short quick asymmetrical steps, and dragged the paretic toe at the beginning of 
swing phase of the paretic leg due to limited dorsiflexion of the ankle. There was 
a noticeable hip hiking and circumduction of the paretic lower extremity through 
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Figure BE. Swing Time Percentage - Subject 3. 
phase of gait. The subject's paretic foot contacted the floor in a foot-flat position 
during initial contact of the gait cycle. 
The paretic upper extremity was held in a flexion synergy pattern with the 
arm internally rotated, abducted, elbow flexed, supinated forearm, wrist flexed, 
and fingers flexed with a closed fist. The arm was held stiff and did not appear 
to move. The non-paretic upper extremity was very ridged looking during and 
was held in a stable position with the shoulder neutral at the side of the trunk 
with slight elbow flexion, and a neutral wrist position. The elbow was flexed 
slightly to advance the cane. Subject also appears to have the ability to weight 
shift with small steps throughout gait on both lower extremities. See Appendix F 
for DVD of subject walking. 
Discussion 
This subject had a flexed posture, shortened step length, limb 
circumduction, and pelvic hiking as major compensations during ambulation . 
, 
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Ambulation velocity did not improve for this subject when the 9.5 mm heel lift 
was inserted. Normal velocity for a healthy adult with no health impairments in 
the 70th decade is 79.8 m/min.18 The subject actually had a slower velocity 
(27.48 m/min) with the lift in. 
Step length on the paretic lower extremity increased when the heel lift was 
used (5.6% change). These findings may have been due to the increased 
amount of clearance as a result of the 9.5 mm heel lift height on the non-paretic 
limb. 
Single limb support for the subject decreased on the paretic limb and 
swing phase decreased on the non-paretic lower extremity with the 9.5 mm heel 
lift in the shoe. In addition, step length decreased on the non-paretic limb with 
the heel lift because he spent less time in stance phase of the gait cycle on the 
paretic lower extremity. It was expected that the subject would have increased 
single limb support on the paretic side, increased swing time on the non-paretic 
side, and an increased step length with the non-paretic leg. 
Overall, the use of the heel lift with this subject did not considerably 
change his gait parameters. This could be due to his marked asymmetry in 
weight-bearing through the lower limbs in static standing (77% non-paretic and 
23% paretic). 
Case Study 4 
Subject 4 was a 61-year-old male, 5 feet 9% inches, who had right 
hemiparesis resulting from a stroke 2.5 years ago. Past medical history included 
a loss of sensation on the right side due to the stroke. He wore an older AFO on 
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the right and used a single point cane occasionally for ambulation. Subject 
reported that he could ambulate 40 to 50 feet. Verbal expression as limited but 
auditory comprehension was functional with cues and demonstrations. He relied 
on his wife for most activities, including driving and answering questions. The 
subject stated that he had a history of falls as well as has difficulty navigating 
curbs in the community (Figure 9A). 
Subject 9A. Subject 4 completing a walk across the GAITRite®. 
Objective Measurements 
Sensation to light touch following dermatomes L4-S2 was normal on the 
non-paretic and absent on the paretic limb. Sitting active range of motion for 
active ankle dorsiflexion measured _2 ° on the non-paretic and foot held in 30° of 
plantarflexion on the paretic limb. Leg length measurement with shoes on for the 
non-paretic limb was 98 centimeters and the paretic limb was 96 centimeters. 
Heel height measured 2.5 centimeters on both shoes. Using the Balance 
Maste~ weight bearing ratio was 73.3% on the non-paretic limb and 26.7% on 
the paretic limb. 
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Data Analysis 
Gait velocity without heel lift was 17.16 mlmin decreased to 16.53 mlmin 
with the heel lift. Percent change for velocity in this subject was -3.7% with the 
heel lift (Figure 98). 
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Figure 98. Velocity - Subject 4. 
The step length on the non-paretic limb decreased from -1.5 cm to -2.8 
cm with lift inserted. When looking at the individual step lengths during the two 
conditions, it is evident that the subject varies from a positive to a negative with 
his non-paretic step length. This variation indicates that the subject does not 
necessarily have a negative step length but rather that the overall average was 
negative. A negative step length is indicated when the non-paretic heel did not 
pass the paretic heel (Table 3). 
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Table 3. Comparison of Step Length for Subject 4. 
Non-Paretic Step Length 
Step Number Lift No Lift 
1 -2.695 cm 5.393 cm 
2 -8.699 cm -0.102 cm 
3 3.976 cm 0.805 cm 
4 -11 .288 cm -4.956 cm 
5 4.692 cm 1.918 cm 
6 3.168 cm -2.749 cm 
7 1.054 cm 0.333 cm 
8 0.278 cm -6.101 cm 
9 2.548 cm -9.397 cm 
The paretic limb had an increase in step length with the heel lift inserted 
from 41.1 cm to 41.5 cm. This indicates a percent change of 1.0% with the heel 
lift (Figure 9C). 
Single limb support for the paretic limb was 13.3% without the heel lift and 
decreased to 13.1 % with the heel lift. The non-paretic limb had a single limb 
support of 46.8% without the heel lift and decreased to 44.5% with the heel lift. 
Percent change for the paretic limb was -1.5% and for the non-paretic limb was -
4.9% with the heel lift (Figure 9D). 
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Figure 90. Single Limb Support - Subject 4. 
Swing time for the paretic limb was 46.8% without the heel lift and 
decreased to 44.6% with the heel lift. The non-paretic limb had a swing time 
percentage of 13.3% without the heel lift and decreased to 13.1 % with the heel 
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lift inserted. Percent change for the paretic limb was -4.7% and for the non-
paretic limb was -1.5% with the heel lift (Figure 9E). 
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Observational Gait · 
Through video observation, this subject showed obvious lower extremity 
extensor synergy pattern on the right as well as a wide base of support. There 
was no hip, knee, or ankle movement during the whole gait cycle for the right 
limb. The non-paretic limb was externally rotated to compensate for the 
internally rotated extensor pattern on the paretic limb. During paretic step, the 
subject maintained a plantarflexed and supinated position of the paretic foot and 
never achieved right heel strike. He utilized a step-to-gait with advancement of 
the paretic foot forward followed by stepping to with the non-paretic foot which 
resulted in a negative step length. Due to increased tone in the right upper 
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extremity, arm swing was not observed during any part of the gait cycle. See 
Appendix F for DVD of subject walking. 
Discussion 
Normal velocity for a 60th decade old is 81.5 m/min.1B This subject was 
significantly below the norm for his age and gender, which would be expected 
due to the extent of his hemiparesis and tone. Balance was a concern due to 
the high amount of instability that this subject portrayed with weight-bearing on 
the paretic limb, and the structural stability of his AFO was a concern. The 
subject should maintain a plantarflexed and supinated position of the paretic foot 
if the AFO was working properly. 
This subject was very interesting in the fact that he did not have a positive 
step length on the non-paretic limb. When observing the video, it became 
apparent that the subject used a step-to pattern, he would advance the paretic 
leg and step up to but not past the non-paretic leg. He may have compensated 
due to the lack of balance or an unstable AFO. Step length is the distance 
between successive heel contacts of the two different feet. The negative values 
that were obtained from the GAITRite® can be explained by the large amount of 
lower extremity tone. This tone inhibited the subject from stepping through on 
the swing phase of the left. 
The other aspects of gait did not have a significant change and it seems 
that the heel lift did not have any effect on his gait parameters. Wearing an AFO 
may have limited his ability to walk successfully with the trial heel lift. He wore 
his AFO on the right foot and the heel lift was inserted in the left shoe. The AFO 
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does provide added height in the shoe similar to a heel lift. It seems that a heel 
lift may not be a suitable solution for all hemiparetic subjects and that she may 
have to be selective when incorporating this intervention. The high amounts of 
tone as well as the negative step length seemed to be limiting factors for the 
effectiveness of this intervention. 
Case Study 5 
Subject 5 was a 74-year-old male, 6 feet 3% inches, who had right 
hemiparesis resulting from a stroke 2 years ago. Past medical history included 
diabetes, asthma, prostate tumor, low blood pressure, dizziness when arising 
from lying too quickly, and arthritis in left shoulder. At the time of the study, 
subject did not wear any glasses but normally does at home. He does not use 
any assistive device or orthotic during ambulation. The farthest distance the 
subject stated he could walk was approximately :4 mile independently. He has a 
history of occasionally falling when the ground in uneven (Figure 10A). 
Objective Measurement 
Sensation to dermatomes L4-S2 bilaterally were normal to light touch, and 
sitting active ankle dorsiflexion range of motion on the non-paretic was 12 
degrees and 5 degrees of the paretic. Leg length measurement with the shoes 
on was 106 cm of the non-paretic limb and 106 cm on the paretic limb. The heel 
height of the shoes was 2.5 cm on the left and right. Weight-bearing ratio was 
60.3% on the non-paretic limb and 39.6% on the paretic limb. 
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Figure 10A. Subject 5 completing a walk across the GAITRite®. 
Data Analysis 
Gait velocity without the heel lift was 60.85 m/min and decreased to 54.48 
m/min with the heel lift. Percent change was -10.5% with the heel lift (Figure 
108). 
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Step length for the paretic limb without a heel lift was 52.78 cm and 
decreased to 49.76 cm with the heel lift inserted. Step length for the non-paretic 
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limb without a heel lift was 64.97 cm and decreased to 61.35 cm with the heel 
lift. Percent change for the paretic limb was -5.7% and for the non-paretic limb 
was -5.6% with the heel lift (Figure 10C). 
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Single limb support for the paretic limb without the heel lift was 33.4% and 
decreased to 31.4% with the heel lift. The non-paretic limb single limb support 
without a heel lift was 32.7% and increased to 34.1 % with the heel lift inserted. 
Percent change for the paretic limb in single limb support was -6.0% and for the 
non-paretic limb was 4.3% with the heel lift (Figure 100). 
Swing time percentage for the paretic limb without a heel lift was 33% and 
increased to 33.7% with the heel lift inserted. The non-paretic limb had a swing 
time of 33.1 % without the heel lift and that decreased to 31.8% with the heel lift. 
Percent change for the paretic limb was 2.1 % and for the non-paretic limb was -
3.9% with the heel lift (Figure 10E). 
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Figure 1 DO, Single Limb Support - Subject 5, 
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Figure 1 DE. Swing Time Percentage - Subject 5, 
Observational Gait 
Through video observation, a flexed posture was apparent throughout the 
gait cycle, The subject had some subtle asymmetry in his gait pattern as 
'-
45 
compared to the other subjects that had more involved hemiparesis. There was 
no arm movement on paretic involved arm and only slight elbow flexion on the 
non-paretic arm during gait. The non-paretic shoulder was depressed slightly 
and the trunk appeared to sway to the left side during swing phase of the paretic 
leg. The non-paretic foot toed out and the paretic foot remained in a neutral 
forward position. There was less hip flexion during initial swing phase on the 
paretic limb of the gait cycle. The subject took a slower step with the paretic leg 
and a quicker step on the non-paretic leg. See Appendix F for DVD of subject 
walking. 
Discussion 
When observing the subject walking, the symmetry of the subject 
ambulating on the GAITRite® showed some slight changes under the testing 
parameters with the use of the 9.5 mm heel lift. The normal velocity for his age 
group was 79.8 m/min without any pathological impairment. 18 Walking velocity 
did decrease when the heel lift was used. This may be due to the more stance 
time on the non-paretic leg when the heel lift was in the shoe. Step length for 
the paretic limb and the non-paretic limb decreased when the heel lift was used. 
This may be due to the alteration of both the right and left stance limb when the 
heel lift was used. Fatigue may have affected his gait parameter results since 
his stride was large and required more walking trials than the other subjects to 
get 20 steps. 
Single limb support decreased on the paretic when the heel lift was used. 
On the non-paretic leg, the single limb support increased with the use of the heel 
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lift. These results are not expected findings when the heel lift is used. These 
results may be because of the decreased velocity of ambulation with the use of 
the heel lift. The subject may spend more time on the non-paretic leg because 
he tended to say to the left during stance phase on the non-paretic leg. 
Swing phase for the paretic leg during gait increased with the use of the 
heel lift. The subject's velocity decreased and he spent more time on the non-
paretic leg during stance phase with the heel lift. It was expected that using the 
heel lift would have the opposite effect and he would spend more time on the 
paretic limb in single limb support allowing for longer swing time on the non-
paretic limb. He subjectively reported that he felt wearing the heel lift improved 
his ability to walk and decreased toe drag. As a result of these positive findings, 
the subject was given a 9.5mm heel lift to use on a trial basis. 
CHAPTER V 
SUMMARY AND CONCLUSION 
Each individual case was looked at and analyzed for specific gait 
deviations. There were some similarities and notable differences between each 
case. The research questions that were addressed include: Does wearing a 
heel lift on the non-involved side improve ambulation for people with hemiparesis 
and does wearing a heel lift improve symmetry of gait? The overall outcome for 
heel lift use in this case series will be addressed. 
All of the individuals in this study had decreased velocity, cadence, stride 
length, and asymmetrical step length which are all typical of a hemiparetic gait 
pattern.2 Another distinctive gait deviation was the increased time spent on the 
uninvolved limb during stance phase. When looking at velocity for the five 
participants in this study, two subjects had an increase in velocity with the heel 
lift inserted. Subject one had a 2.4% increase in velocity and subject two had a 
7.4% increase in velocity. Aruin et al2 has identified gait velocity to be a 
determinant of functional return in people with hemiparesis. Although these 
subjects had an increase, they were still well below normal velocity for their age. 
Step length improved in one of the five subjects when ambulating with the 
heel lift insert. Contrary to Aruin et al's2 work, this study chose to look at step 
length instead of stride length when analyzing gait. If there is an asymmetry with 
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step length, this discrepancy will not necessarily show up in stride length. Stride 
length can appear normal or unchanged even if an asymmetry is present. 
According to the results of Ariun's2 study, gait velocity was correlated with stride 
length. As gait velocity increases, stride length increased and gait velocity 
decreased, stride length decreased. 
Single limb support did not increase on the paretic lower extremity using 
the heel lift on any of the subjects in this study. As stated by Bohannon,8 it is 
common for people with hemiparesis to have difficulty supporting weight on their 
paretic limb. The heel lift in studies measuring static weight bearing showed 
increased weight acceptance on the paretic side.2-4 Non-paretic swing phase did 
not improve in any of the subjects in this study. The subject spent more time on 
their non-paretic leg during swing phase. Swing phase for the non-paretic limb 
cannot improve if there is decreased weight acceptance on the paretic side. 
Limitations/Recommendation of Study 
One of the limitations of the study is that the 9.5 mm heel lift was only 
administered for a very short length of time. It is not known that if the subjects 
were to wear the heel lift for a greater time period and be tested again if there 
would be more notable changes in the gait parameters. In future studies, the 
heel lift should be given for a greater period of time to each individual to use so 
he/she can learn to walk with it. The results should be compared to initial use 
and again after the lift has been used for a given time frame, as demonstrated by 
Aruin et al,2 when a single subject participated in walking trials after wearing the 
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heel lift for six weeks. There and used may be changes in gait parameters after 
the subject has used the heel lift for an extended period of time. 
The small sample size of adults with hemiparesis is another limitation of 
the study. This study became a case study series due to the limited number of 
subject and used only descriptive statistics. A larger sample size of individuals 
with hemiparesis would be recommended to be able to run statistics to get 
significant results of the gait parameters. 
Some subjects in the study wore an AFO during the walking trials and 
some did not. The use of an AFO may have an effect on the outcome of a heel 
lift insertion. In order to compensate for the AFO, a larger heel lift might be 
needed. It is also not known if the heel lift adjusted enough to the AFO height 
itself. It does not appear that the height of the AFO played any significant factor 
in any gait parameters when used with the heel lift. Only three subjects in the 
study wore AFOs and no significant changes were apparent in their results. Two 
leg length measurements should have been taken, the first with shoes on without 
the lift and the second with the lift inserted. This would have allowed for 
comparison of the effects of an AFO. More research is needed to find out 
whether the use of an AFO will alter the effects of a heel lift. 
Another limitation is the length of time the subject has had hemiparesis. 
Previous studies from Chaudhuri et al4 and Rodriguez et al3 used a heel lift to 
improve weight-bearing symmetry in subjects with more acute hemiparesis. 
Work by Aruin et al2 used subjects in the acute, sub-acute, and chronic stages. 
Each of our subjects had hemiparesis ranging from 2 years to 11 years which 
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more closely resembled the demographics of the study by Aruin et al.2 Each 
individual has learned compensatory strategies for his/her hemiparesis and a 
onetime use of a heel lift may not affect gait parameters. Some subjects were 
currently trying or had already tried a heel lift as an intervention. The height of 
the heel lift, reason for use, or the length of time used was not known for 
subjects who had worn heel lifts in the past. What would be the effects of a heel 
lift after a more acute episode of hemiparesis or more long-term hemiparesis? 
The amount of time the individual has hemiparesis should be more standardized 
to get accurate results. Aruin et al's2 subjects ranged from 0.16 years to 5 years 
post-hemiparesis from a unilateral stroke. The subjects should not have already 
tried the heel lift for an intervention prior to the study. This may account for 
some unwanted limitations. 
Additional limitations of the study are stated below. There was a high 
variability in each of the subjective and objective measurements including side of 
hemiparesis, degree of sensation loss, ankle dorsiflexion ROM, and degree of 
asymmetry in static weight-bearing. If the dominant hemisphere is involved for 
the individual in our study, then this could make a difference on learned use of 
the heel lift. These variables could be better controlled by setting stricter 
limitations for inclusion into the study. 
The individuals in this study were not measured during static weight-
bearing after the heel lift was inserted. Measuring static weight-bearing on the 
Balance Maste~ would have allowed comparison of weight-earing ratios with 
and without the heel lift. This information would then determine whether wearing 
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a heel lift promoted weight shifting onto the paretic limb in quiet standing as 
reported by Aruin et al.2 
Assistive devices were used for the subjects that normally used them for 
ambulation. Assistive devices were allowed but not required, and three subjects 
used a single point cane. The use of an assistive device could have altered the 
heel lift effects on gait parameters. It is unclear what effects the use of an 
assistive device had on the gait parameter results. 
Single limb support time for the paretic limb and swing time for the non-
paretic limb are measurements of the same gait parameters. This was evident in 
the results of this study when calculating percent change for these parameters. 
It would have been more beneficial to look at another gait parameter, such as 
stride length. 
Clinical Implications 
The findings of this study are limited and may not be appropriate for every 
individual with hemiparesis. The use of a heel lift should always be 
individualized to the patient when attempting to use it for physical intervention to 
improve gait in clinical setting. By observing the characteristic gait pattern of a 
subject with hemiparesis, it should be apparent whether a heel lift would benefit 
the individual or not. It is much easier to observe changes in gait with the use of 
a computerized walkway, such as the GAITRite® compared to observation alone. 
The use of the heel lift can improve the clearance of the involved leg during 
swing phase of gait when the patient has a difficult time clearing the foot. 
Velocity has been shown to increase in one subject post stroke after wearing the 
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heel lift for 6 weeks y Aruin et al.2 Slower walking requires greater energy 
consumption and greater balance. If the heel lift improves weight shifting and 
gait velocity after 6 weeks of use, this may help patients with hemiplegia improve 
their functional ambulation. Short-term results of the heel lift according to this 
study do not indicate that the use of a heel lift improves gait velocity immediately. 
This would be a fairly inexpensive intervention treatment option to improve foot 
clearance of the involved leg and gait velocity with long-term use. 
Conclusion 
A heel lift under the non-paretic limb improves weight-bearing on the 
paretic limb during static stance. 2-4 This study looked at how a heel lift affected 
gait parameters (velocity, step length, swing/SLS) in five subjects with unilateral 
hemiparesis. No definite conclusions can be made from this study. A heel lift 
under the non-paretic limb improved gait velocity and symmetrical step length in 
one subject. A second subject reported subjective benefits of wearing a heel lift. 
A heel lift may be an affordable option to improve gait in certain individuals with 
less hemiparetic involvement and a more symmetrical weight-bearing ratio. The 
individuals with a greater degree of hemiparesis in this study did not benefit from 
the use of the heel lift. Further research is needed to determine if a heel lift is 
more effective after a longer duration of use. 
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University of North Dakota Institutional Review Board 
Date: 4/26/2007 Project Number: . IRB-200704-325 
--~~-=~~~~~----------------
Principal Investigator: Danks, Meridee; Avery, Bryan; Riley, Lindsay; Webster, Shannon 
Department: Physical Therapy 
Project Title: The Effects of a Heel Lift on Gait Parameters During Ambulation for People with Hemiparesis 
The above referenced project was reviewed by a designated member for the University's Institutional Review Board 
A ri 1 2 20 and the following action was taken: 
roject approved. Exped ited Revi ew Category No. ------L..,.r----------------------,.----------------__ 
Next sch edu I ed review must be before: Ap F'-,-r ..... i ..... 1~2.><.6.,..>---'_2>L0>L0'_'.8 _____________________________________ _ 
[] Copies of the attached consent form with the IRS approval stamp dated Apr; 1 27. 2007 
must be used in obtaining consent for this study. 
Project approved. Exem pt Review Category No. ________________________________________________ _ 
D This approval is valid until as long as approved procedures are followed. No 
periodic review scheduled unless so stated in the Remarks Section. 
o Copies of the attached consent form with the IRB approval stamp dated 
must be used in obtaining consent for this study. 
D Minor modifications required. The required corrections/2dditions must be submitted to ROC for review and 
approval. This study may NOT be started UNTIL final IRS approval h2s been recsived. 
D Project approval deferred . This study may not be started until finallRB approval has been received. 
(See Remarks Section for further information.) 
D Disapproved claim of exemption. This project requires Expedited or Full Board review. The Human Subjects 
Review Form must be filled out and submitted to the IRB for review. 
D Proposed project is not human subject research and does not require IRB review. 
o Not Research 0 Not Human Subject 
PLEASE NOTE: Re:; L!~':':~9d revisions for stud snt proposcJs MUST inclu[:& 2~: vise/~ sig nature. All revisions 
MUST be highlighted. 
,I29~d ucation Requirements Completed. (Project cannot be started untillRB education requirements are met.) 
·1 
cc: Chair, Physical Therapy 
If the proposed project (clinical medical) is to be part of a research activity funded by a Federal Agency, a speciel assurailce 
statement or a compleied 310 Form may be required . Contact ROC to obtain the required document:: . 
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University of North Dakota Human Subjects Review Form 
All research with human paliicipants conducted by faculty, staff, and students associated with the University ofNOlih Dakota, 
must be reviewed and approved as prescribed by the University's policies and procedures governing the use of human subjects. 
It is the intent of the University of North Dakota (UND), through the Institutional Review Board (IRE) and Research 
Development and Compliance (RD&C) , to assist investigators engaged in human subject research to conduct their research 
along ethical guidelines reflecting professional as well as community standards. The University has an obligation to ensure 
that all research involving human subjects meets regulations established by the United States Code of Federal Regulations 
(CFR). When completing the Human Subjects Review Form, use the "IRE Checklist" for additional guidance. 
Please provide the information requested below: 
Principal Investigator: Meridee Danks, Bryan Avery, Lindsay Riley, Shannon Webster 
Telephone: 701-777-3861 E-mail Address: mgreen@medicine.nodak.edu 
Complete Mailing Address: Department of Physical Therapy 
University of North Dakota 
School of Medicine and Health Sciences 
PO Box 9037 
501 N. Columbia Road 
Grand Forks, ND 58203 
School/College: University ofNOlill Dakota Department: Physical Therapy 
Student Adviser (if applicable): Meridee Danks 
----------------------------------------------------------------
Telephone: 701-777 -3861 E-mail Address: 
Address or Box #: 
---------------------------------------------------------------------------
School/College: Department: 
--------------------------------- ----------------------------------
Project Title: The effects of a heel lift on gait parameters during ambulation for people with hemiparesis. 
Proposed Project Dates: Beginuing Date: May 2007 
----------~----------
Completion Date: May 2008 
--~~~~~--~~~-­(Including data analysis) 
Funding agencies supporting tlus research: UND PT Department 
--------------------------------------------------------
Did the contract with the funding entity go through UND Grants and Contracts Administration? D YES or D NO 
Attach a copy of the contact. Do not include the any budgetary infonnation. The IRE will not be able to review the study 
without a copy of the contract with the funding agency. 
D YES or IZl NO 
Does any researcher associated with this project have an economic interest in the research, or act as an 
officer or a director of any outside entity whose fmancial interests would reasonably appear to be 
affected by the research? If yes, submit on a separate piece of paper an additional explanation of the 
financial interest. The Principal Investigator and any researcher associated with this project should 
have a Financial Iuterests Disclosure Document on file with their department. 
Will research subjects be recruited at another organization (e.g., hospitals, schools, YMCA) or will 
D YES or IZl NO assistance with the data collection be obtained from another organizatiou? 
If yes, list all institutions: 
Letters from each organization must accompany this proposal. Each letter must illustrate that the organization uuderstands 
their involvement in that study, and agrees to participate in the study. Letters must include the name aud title of the 
individual signing the letter and should be printed on letterhead. 
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Does any external site where the research will be conducted have its own IRE? 0 YES 0 NO ~ N/A 
If yes, does the external site plan to rely on UND's IRB for approval of this study? 0 YES 0 NO 0 N/A 
(If yes, contact the UND IRE at 701 777-4279 for additional requirements) 
If your proj ect has been or will be submitted to other IREs, list those Boards below, along with the status of each proposal. 
___________________ Date submitted: Status: 0 Approved 0 Pending 
Date submitted: 
----------------------
------
Status: 0 Approved 0 Pending 
(include the name and address of the IRE, contact person at the IRE, and a phone number for that person) 
Type of Project: Check "Yes" or "No" for each of the following. 
~ YES or 0 NO New Project 0 YES or ~ NO Dissertation/Thesis/Independent Study 
0 YES or ~ NO ContinuationlRenewal ~ YES or 0 NO Student Research Project 
Is this a Protocol Change for previously approved project? If yes, submit a signed copy of this form with 
0 YES or ~. NO the changes bolded or highlighted. 
Does your project involve abstracting medical record infonuation? If yes, complete the HIP AA 
0 YES or ~ NO Compliance Application and submit it with this fon11. 
0 YES or ~ NO Does your project include Genetic Research? 
0 YES or ~ NO Does your project include Internet Research? 
Subject Classification: This study will involve subjects who are in the following special populations: Check all that apply. 
o Children « 18 years) 0 UND Students 
o Prisoners 0 Pregnant WomenlFetuses 
o Persons with impaired ability to understand their involvement and/or consequences of participation in this research 
~ Other Persons with hemiparesis from the community 
Please use appropriate chec1dist when children, prisoners, pregnant women, or people who are unable to consent will be 
involved in the research. 
This study ,'Vill involve: Check all that apply. 
o Deception (Attach Waiver or Alteration of Informed 
Consent Requirements) o Stem Cells 
o Radiation o Discarded Tissue 
o New Drugs (IND) Il\T]) # _Attach Approval o Fetal Tissue 
o Investigational Device Exemption (IDE) # _Attach Approval o Human Blood or Fluids 
o NOll-approved Use ofDrug(s) o Other 
~ None of the above will be involved in this study 
I. Proiect Overview 
Please provide a brief explanation (limit to 200 words or less) of the rationale and purpose of the study, introduction of any 
sponsor(s) of the study, and justification for use of human subjects and/or special populations (e.g., vulnerable populations such 
as children, prisoners, pregnant women/fetuses). 
1. The purpose of tillS research study is to determine the effect of a heel lift insert under the non involved leg on 
walking parameters in people with hemiparesis. Previous research has shown how a heel lift insert improves weight 
bearing symmetry in static balance for those people with henllparesis. People with hemiparesis can have a deficit to 
varying degrees in symmetry to the involved side during dynamic activities such as gait, and may have diminished 
function if an asymmetry is present. Cun'ently, there is little research describing the effects of a heel lift involving 
dynamic walking with this patient population. Human subjects with hemiparesis are required in the current research 
proposal in order to generate new data on this patient population relative to dynamic walking. 
II. Protocol Description 
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Please provide a succinct description of the procedures to be used by addressing the instructions under each of the following 
categories. 
1. Subject Selection. 
a) Describe recruitment procedures (i.e., how subjects will be recruited, who will recruit them, where and when they will be 
recruited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects. 
Human subjects will be recruited to participate in this study through personal phone calls, email, andlor mail. The 
principal investigator and student researchers will recruit subjects during summer 2007. Recruitment will take place 
within the Physical Therapy Department at the U1\lJ) Medical School. For this study, advertisements andlor flyers will not 
be utilized. 
b) Describe your subject selection procedures and criteria, paying special attention to the rationale for including subjects from 
any of the categories listed in the "Subject Classification" section above. 
Human subjects will be selected based on their diagnosis of either left or right hemiparesis, having the diagnosis 6 plus 
months post-injury/incident leading to hemiparesis, age 18 years or older, and male or female gender. Subjects will be 
able to, follow two-step directions, walk independently for at least 80 feet, have an asymmetric static posture exhibiting 
more than 55% of body ,,,eight dispersed on the non involved leg, and own laced shoes that do not have more than a half 
inch heel. 
c) Describe your exclusionary criteria and provide a rationale for excluding subject categories. 
Subjects will be excluded by the following criteria: any unstable medical condition, other neurological diseases, severe 
visual or vestibular deficits, trauma, other orthopedic problems directly affecting walking/balance, and any other factors 
that would prevent full participation within this study. 
d) Describe the estimated number of subjects that will participate and the rationale for using that number of subjects. 
We plan to utilize up to 30 subjects for this study. Due to tinle constraints tlle number of subjects will be limited. 
e) Specify the potential for valid results. If you have used a power analysis to determine the number of subjects, describe 
your method. 
2. Description of Methodology. 
a) Describe the procedures used to obtain informed consent. 
The subject will read the consent form and provide a signature. They will also receive a copy of this document. This 
document will contain a detailed description of the procedures, inherent risks to the subjects through participation, and 
privacy issues regarding the collection of personal data. 
b) Describe where the research will be conducted. Document the resources and facilities to be used to carry out the proposed 
research. Please note staffing, funding, and space available to conduct this research. 
Tilis project will be conducted within the Physical Therapy Department located at tlle UND School of Medicine and Health 
Sciences. All equipment and instrumentation, as listed in the research protocol, are available within the department. There is 
ample space to perform the research witllin this department. 
c) Indicate who will carry out the research procedures. 
The research will be conducted by Bryan Avery, SPT, Lindsay Riley, SPT, and Shannon Webster, SPT. This project will be 
supervised by Dr. Meridee Danks. 
d) Briefly describe the procedures and techniques to be used and the amount oftime that is required by the subjects to 
complete them. 
1. The subj ect will read the consent form and provide a signature. 
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2. The participant will complete a health history questionnaire to provide some insight and detemune 
eligibility in the study. Both the consent fonu and questiOlmaire will take five minutes to read and 
complete. 
3. If the participants do not meet the inclusion criteria as listed above, they will be thanked for their time and 
dismissed from the study but will be given the option to complete the GAlTRite component if they so wish. 
Data for these subjects will not be included in the study. 
4. The participants' height will be measured in centimeters with shoes on. A pencil mark will be made on the 
wall and the researcher will measure the height ii-om the ground to the pencil mark. 
S. The participant will stand on the Balance Master® (an instIllment that detenuines body weight distribution) 
to detennine if an asymmetry is present for inclusion into the study. If the participant does not have an 
asynunetry present they will be thanked for their time and dismissed from the study. Set up and data 
collection is expected to take 1-2 minutes. The data will be saved on the computer and recorded on an 
individual data collection fonu. 
6. The areas being assessed are: 
1. Sensation testing will be perfomled in sitting. 
11. Range of motion of the ankle joint will be measured using a goniometer in sitting with the knee 
bent. 
lll. Both of these measurements will take a total of S minutes to measure and record. 
7. The pa11icipants will randomly select a number out of a can to detemune the order in \vluch they wear the 
heel lift. 
8. Leg length will be measured in standing with shoes on. 
9. The pru1icipants will be instIllcted to walk at a comfortable rate along the GAlTRite® walkway (a 
computerized carpet that measures walking parameters). An X will be placed on the far wall for the 
participants to focus on while walking to encourage the subject to look up. The subject will walk an extra 
6ft at both ends to allow for acceleration and deceleration of gait. The participants will be given the 
opportunity to "practice" one time walking down and back on the on the computerized carpet. The 
participants will walk up and down the computerized carpet with and without a heel lift. Twenty steps will 
be obtained for each treatment condition. The pa11icipants will then be given a maximum of S minutes to 
recuperate, then asked to repeat the procedure under the second randomly assigned condition. It should take 
four or five walks along the computerized carpet to obtain twenty steps. The data will be saved on the 
Balance Master® and GAlTRite® for later analysis. 
e) Describe audio/visual procedures and proper disposal of tapes. 
N/A 
f) Describe the qualifications of the individuals conducting all procedures used in the study. 
All researchers have been instructed in the proper technique for perfonning the above tests as outlined in question 2d. The 
researchers are currently second year students in the Doctorate of Physical Therapy program at UND. Dr. Meridee Danks is 
an Assistant Professor of Physical Therapy and Doctor of Physical Therapy at UND and has worked as a PT for twenty five 
years. 
g) Describe compensation procedures (payment or class credit for the subjects, etc.). 
The subjects will not receive monetary compensation for their participation. Individuals that do not meet inclusion criteria 
will still be able to walk on the computerized carpet and will receive a free copy of the data collected. 
Attachments Necessary: Copies of all instruments (such as survey/interview questions, data collection fonus completed by 
subjects, etc.) must be attached to this proposal. 
3. Risk Identification. 
a) Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might 
result from this study. 
There is minimal risk involved with participating in this study. This includes fatigue and a nUniscule risk of falling. During 
the testing on the Balance Master® and GAlTRite® , a researcher will be available to supervise the subject in order to 
minimize the risk of falling. There is no apparent emotional or fmancial risk involved. 
b) Indicate whether there will be a way to link subject responses and/or data sheets to consent fonus, and if so, what the 
justification is for having that link. 
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There will be no link between the consent form and the participants data collected in this study. 
c) Provide a description of the data monitoring plan for all research that involves greater than minimal risk. 
N/A 
d) If the PI will be the lead-investigator for a multi-center study, or if the PI's organization will be the lead site in a multi-
center study, include infomlation about the management of infoDnation obtained in multi-site research that might be 
relevant to the protection of research participants, such as unanticipated problems involving lisks to participants or others, 
interim results, or protocol modifications. 
N/A 
4. Subject Protection. 
a) Describe precautions you will take to minimize potential risks to the subjects (e.g. , sterile conditions, infoDning subjects 
that some individuals may have strong emotional reactions to the procedures, debriefmg, etc.). 
There is minimal risk because the subjects are independent in walking. A spotter and gait belt will be provided during data 
collection to ensure the safety of the participants. 
b) Describe procedures you will implement to protect confidentiality and privacy of participants (such as coding subject data, 
removing identifying infomlation, reporting data in aggregate fonn, not violating a participants space, not intruding where 
one is not welcome or trusted, not observing or recording what people expect not to be public, etc.). Ifparticipants who are 
likely to be vulnerable to coercion and undue influence are to be included in the research, defme provisions to protect the 
privacy and interests of these participants and additional safeguards implemented to protect the rights and welfare of these 
participants. 
All information that is collected during this study will remain confidential and there will not be a link from the consent 
fomls to the data collected. In order to ensure subject confidentially, subjects will be assigned a number at the 
commencement of the study. This number will be the primary identifier for that subject through the remainder of the 
study. 
c) Indicate that the subject will be provided with a copy of the consent fODn and how this will be done. 
Subjects will receive a copy of the consent fonn after they have signed the consent fonn that ,,,ill stay within the 
dep artment. 
d) Describe the protocol regarding record retention. Please indicate that research data from this study and consent forms will 
both be retained in separate locked locations for a minimum of three years following the completion of the study. 
Describe: 1) the storage location of the research data (separate frOID consent fonns and subject personal data) 
2) who will have access to the data 
3) how the data will be destroyed 
4) the storage location of consent fonns and personal data (separate from research data) 
5) how the consent fonns will be destroyed 
1) The data will be located in a locked file cabinet within the Physical Therapy Department (separate from consent fonns). 
2) The PI, student researchers and officials that may audit research documents. 
3) Data will be shredded after 3 years. 
4) The consent forms will be in a locked file cabinet within the Physical Therapy Department (separate from research 
data). 
5) Fomls will be shredded after 3 years. 
e) Describe procedures to deal with adverse reactions (refeuals to helping agencies, procedures for dealing with trauma, etc.) . 
If a fall or other adverse events occur medical persomlel will be contacted. 
f) Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs 
involved. 
UND and the Physical Therapy Department will not be held liable for medical costs associated with the incident. 
III. Benefits of the Study 
Clearly describe the benefits to the subject and to society resulting from this study (such as learning experiences, services 
received, etc.). Please note: extra credit and/or payment are not benefits and should be listed in the Protocol Description section 
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under Methodology. 
The subjects may not benefit personally from being in this study. However, in the future other people might benefit 
from this study by having results that may lead to a new approach to treating people with hemiparesis. Upon request, 
subjects will be given a copy of the results from tlus study. 
IV. Consent Form 
A copy of the consent form must be attached to tIlis proposal. If no consent fonu is to be used, document the procedures to be 
used to protect human subjects, and complete the Application for Waiver or Alteration ofInformed Consent Requirements. Refer 
to fonn IC 70l-A, Informed Consent Checldist, and make sure that all the required elements are included. Please note: All 
records attained must be retained for a period of time sufficient to meet federal, state, and local regulations; sponsor 
requirements; and organizational policies. The consent form must be written in language that can easily be read by the subject 
popUlation and any use of jargon or technical language should be avoided. The consent form should be written at no higher 
than an 8th grade reading level, and it is recommended tIlat it be written in the tIlird person (please see the example on the 
RD&C website). A two inch by two inch blank space must be left on the bottom of each page of the consent form for the IRE 
approval stamp. 
Necessary attachments: 
D Signed Student Consent to Release of Educational Record Fonn (students only); 
D Investigator Letter of Assurance of Compliance; 
D Consent fonu, or Waiver or Alteration of Informed Consent Requirements (Form IC 702-B) 
D Surveys, interview questions, etc. (if applicable); 
D Printed web screens (if survey is over the Internet); and 
D Advertisements. 
By signing below, you are verifying that the information provided in the Human Subjects Review Form and attached 
information is accurate and that the project will be completed as indicated. 
Signatures: ~. o.l Dt1d~~--
~ _-,0 - L(-~?-3-ol 
"<;;IiM ' , /\ 0;, 
~' 
Date: 
Requirements for submitting proposals: 
Additional infonnation can be found on the IRE web site at Yvww.und.nodak.eduJdepUorpd/regucommfIRB/index.html. 
Original Proposals and all attachments should be submitted to Research Development and Compliance, P,O, Box 7134, Grand 
Forks, ND 58202-7134, or brought to Room 105, Twamley Hall. 
Prior to receiving IRE approval, researchers must complete the required IRE human subjects' education. Please go to http:// 
http://wvvw.und.eduidept/rdc/regucommlIRBIIRBEducation.htm for more information. 
The criteria for determining what category your proposal will be reviewed under is listed on page 3 of the IRE Checldist. Your 
reviev;rer will assign a review category to your proposal. Should your protocol require full Board review, you will need to 
provide additional copies. Further infornlation can be found on the RD&C website regarding required copies and IRE review 
categOlies, or you may call the RD&C office at 701 777-4279. 
In cases where the proposed work is part of a proposal to a potential funding source, one copy of the completed proposal to the 
funding agency (agreement/contract if there is no proposal) must be attached to the completed Human Subjects Review Fornl if 
the proposal is non-clinical; 7 copies if the proposal is clinical-medical. If the proposed work is being conducted for a 
pharmaceutical company, 7 copies of the company's protocol must be provided. 
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INVESTIGATOR LETTER OF ASSURANCE OF COMPLIANCE 
WITH ALL APPLICABLE FEDERAL REGULATIONS FOR THE 
PROTECTION OF THE RIGHTS OF HUMAN SUBJECTS 
I /3rYU 1 i\vc,rj ) L'nJSfl.-1 12;/"1.) Skt<J1 ''} W ? l,Ve b5 :k'l ~,J~ Dlvv fe.-
(Name of Investigator) . 
agree that, in conducting research under the approval of the University ofNOlih Dakota Institutional 
Review Board, I will fully comply and assume responsibility for the enforcement of compliance with all 
applicable federal regulations and University policies for the protection of the rights of human subj ects 
engaged in research. Specific regulations include the Federal Common Rule for Protection of the Rights of 
Human Subjects 45 CFR 46. I will also assure compliance to the ethical principles set forth in the National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral Research document, The 
Behnont RepOli. 
I understand the University's policies concerning research involving human subjects and agree to the 
following: 
1. Should I wish to make changes in the approved protocol for this project, I will submit them for 
review PRIOR to initiating the changes. (A proposal may be changed without prior IRE approval 
where necessary to eliminate apparent immediate hazards to the subjects or others. However, the 
IRE must be notified in writing within 72 hours of any change, and IRE review is required at the 
next regularly scheduled meeting of the full IRE.) 
2. If any problems involving human subjects occur, I will inunediately notify the Chair of the IRB, or 
the IRE Coordinator. 
3. I will cooperate with the UND IRE by SUbmitting Research Project Review and Progress Repolis in 
a timely manner. 
I understand the failure to do so may result in the suspen~ion or tennination of proposed research and 
possible repOliing to federal agencies. 
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STUDENT RESEARCHERS: As of June 4, 1997 (based on the recommendation of UNO 
Legal Counsel) the University of North Dakota IRB is unable to approve your project unless 
the following "Student Consent to Release of Educational Record" is signed and included 
with your "Human Subjects Review Form." 
STUDENT CONSENT TO RELEASE OF EDUCATIONAL RECORD1 
Pursuant to the Family Educational Rights and Privacy Act of 1974, I hereby consent to the 
Institutional Review Board's access to those portions of my educational record which 
involve research that I wish to conduct under the Board's auspices. I understand that the 
Board may need to review my study data based on a question from a participant or under 
a random audit. The study to which this release pertains is 
-------------------------
The effects of a heel lift on gait parameters dUling ambulation for people with hemiparesis. 
I understand that such information conceming my educational record will not be released except on 
the condition that the Instihltional Review Board will not pennit any other pmiy to have access to 
such infonnation without my wlitten consent. I also understand that tlus policy will be explained to 
those persons requesting any educational information and that tlus release will be kept with the study 
documentation. 
OS4o C\C\'3> ) 04L1. iD [d- I 01-\ 7 6\ <1'-4:3 
NAID# 
tf/23}07 
Date 
1Consent required by 20 U.S.C. 1232g. 
f3rVl~11 Avel'-j, Lind.s<JJ.l Ki\e..u ,9~ 
Printed Name' 'J -..) , 
>'L_ ~ !1~ tt;& ::1wJ:p 
Signatureo nJdent Res~rchelO 7 
"R F.vi!<F.n 10/15/06 > 
APPENDIX B 
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Title: The effects of heel lift on gait parameters dUling ambulation for people with 
hemiparesis. 
Any persons paliicipating in research must give infomled consent to take pali in the study. 
You must understand the risks involved in research. This document provides infonnation 
that will be impOliant to understand to be involved in the research. Research studies 
include only subjects who choose to participate. Please take your time in making your 
decision as to whether to take pati in tIns research study. If you have any questions, 
please ask at any time. 
You are invited to be in a research study conducted by Dr. Melidee Danks (UND faculty), 
Bryan Avery, Lindsay Riley, and Shatmon Webster (UND physical therapy graduate 
students), about the effects of a heel lift on gait parameters dUling walking for people 
with hemipat·esis. You have been chosen as a potential candidate because of your lnstory 
of hemiparesis. It is known that hemipat"esis involves changes in hip and leg movement 
during walking. 
Up to 30 people will take part in tIns study at the University ofNOlih Dakota School of 
Medicine and Health Sciences Physical Therapy Depatiment. Your patiicipation will last 
approximately one hour if you mee~ the research cliteria to be included in the study. 
After this document has been read, you will be asked to sign it if you agree to take pati in 
the study. You will then be asked to fill out a health questiOlmaire. Following this, your 
height will be measured and you will stand on the Balance Master system® (an 
instrument that detennines the amount of weight on each leg dUling standing). If you do 
not meet the study requirements to tlns point, we will simply thank you for coming. No 
fmiher testing will be administered. If you meet the requirements to tIns point you will 
proceed through the rest of the study process. Sensation will be tested in your legs. Then 
range of motion of your ankles and the length of your legs will be measured. You will be 
asked to pick a number from a can to detennine the order you will be tested. The final 
task of the procedure is to walk on the computerized cat1Jet several times to analyze 
walking. A safety belt will be place on you and a spotter will walk next to you wlnle on 
the computer carpet for safety. Upon completion of the walking the study will be over. 
You may not benefit personally fl.-om being in this study. However, we hope that in the 
future other people might benefit :5."0111 this study by having results that may lead to a new 
approach to treating people with hemiparesis. Upon request, we will give you a copy of 
the results fl.-om this study. You will not be paid for being a paliicipant in tIns research. 
In any repOli about tIns study that might be published, you will not be identified. 
Confidentially will be maintained by assigning you a number at the beginning of the 
study and this infOlmation will only be shared with the individuals conducting the study. 
The infonnation will be locked in a file cabinet to fmiher protect from outside tlll"eats. 
Your study record may be reviewed by govemment agencies, the Ulnversity ofNOlih 
Dakota Research Development and Compliance office, and the University of North 
Dakota Institutional Review Board. 
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In the event of an injury, medical persOlmel will be contacted. Payment for any such 
treahnent is to be provided by you or your third-party payer. No funds have been set 
aside to compensate you in the event of injury. 
Your pcuiicipation is voluntary. You may choose not to padicipate or you may 
discontinue you participation at any time without penalty or loss of benefits to which you 
are othelwise entitled. Your decision whether or not to paliicipate will not affect your 
cunent or future relations with the University of North Dakota. 
If you later have questions, concems, or complaints about the research please contact Dr. 
Meridee Danks at (701-777-3861). If you have questions regarding your rights as a 
research subject, or if you have any concems or complaints about the research, you may 
contact the University ofNOlih Dakota Institutional Review Board at (701-777-4279). 
Your signature indicates that you read and understand the research process, that your 
questions have been answered, and that you agree to take pali in this study. You will 
receive a copy of this fon11. 
Subjects Name __________________________ _ 
Signature of Subject Date 
2 
APPENDIX C 
Health Questionnaire 
Identification number: 
----
Bilih date: 
----
Sex: Male/Female 
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Contact number: 
-----
What condition caused your hemiparesis? 
Which side is involved? 
When did the incident occur? 
Circle if you have or ever have had any of the following 
Anemia YeslN 0 
Diabetes YeslNo 
Thyroid Disorder YeslNo 
Rheumatic Fever YeslNo 
Hemi Disease YeslNo 
Hemi Attack Y eslN 0 
Stroke YeslNo 
Epilepsy YeslNo 
Asthma YeslNo 
Glaucoma Y eslN 0 
Tumors Y eslN 0 
Cancer Y eslN 0 . 
Radiation YeslNo 
High/Low Blood Pressure YeslNo 
Dizziness YeslNo 
Headaches Y eslN 0 
Emphysema YeslNo 
Loss of Sensation YeslNo 
Kidney Disease Y eslN 0 
Pace Maker YeslNo 
Heali SurgelY Y esfN 0 
fuiilli tis Y esfN 0 
Joint Replacement YeslNo 
Ringing in Ears Y eslN 0 
Olihotics Y eslN 0 
Broken bones YeslNo 
Vision YeslNo 
Do you use an assistive device for walking? YeslNo 
(if yes, what type?) _______________ _ 
Please list medications: 
V/hat types of shoes do you normally where? 
What is the fmihest distance you can walk by yourself? 
Do you have a histOlY of falls? If yes, explain. 
APPENDIX D 
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Subject Data Collection Form 
Patient Number 
----
Height (cm) (Shoes on) 
Balance Master 
Weight Bearing Percent: 
Sensation of feet 
Light Touch 
Fill in: Absentiimpaired/nonnal 
Use examiners finger 
ROM (degrees) 
Sitting 
Ankle Dorsiflexion 
Leg Length (em) (Shoes on) 
Greater trochanter to floor 
Left 
LEFT L4 
RIGHT L4 
Random Grouping Assignment for GAITRite 
No Heel Lift 
Heel Lift 
Heel Height of Shoes 
Left 
---
Right __ _ 
L5 
L5 
Sl 
Sl 
S2 
S2 
APPENDIX E 
U D 
501 N Columbia Rd 
P. O. Box 9037 
Tested on: 6/28/2007 '10:48:25 AM 71 
Tel# 7017772831 
Grand Forks NO 58203 [tL~~~L£~cRi~'! fk~~ 
Walk # 1 Footfall # ('URI Mean(%CV) !--mI~I--ml--v4l--USi--w-r-1i7I--uaI--W-I--;I--v11I~ 
StepTIme(sec) l~~_i __ J_ I 1.013 1---I1.1'13C---I----:925I---C988]---. 1 .912_1 I 
I R I .606 (3) I I ~ . .61 2 i I . 6~2 ! 1 .575 1 I .690) I .613 : 
CycleTIme(sec) I. __ ~l 1.595 (5) 1 ~ __ .-' 1 ·~1---.J-~1~~--~~ I 1.512 1 I R r 1.593 {o) , i r- 1.625 ,- , 1.725 I I 1500l 1.588 ' I 1.525 
t---::'~=--:-~---:-
SWing TIme (sec) !_~J .538 (48)/33.7 I~_ 1._ .638 .L __ I~ I~J ___ I_~~~J.. __ -' .537 ~ 
I'lOGC R I .365 (4)/22.9 1--, ~ ' .387 --I-:3s2i ! .350 I 1 .375 ~ .350 I I----...;..;..;.~ 
Stance (sec) U~ (20) 166.3 ! 1.000 1 I .950 'I 1~7 L_~_.~.u ___ I~--.J I ! 
I%GC I =< 1 1.22o(7)m.1 ! j1'2ss i 1:3s3l l 1.150 1 I 1.213 1--1 1·;75 1 I 
t-=--:----:-......,....; 
Single Support (sec) I L 1-.-:.365 (4) '22.9 1 _ _ -1 __ .L2~L , .382 1'. ___ 1 .350 .l~~ __ _'~':J ___ ; 
1 %GC I~ .538 (48) 133.8 I .638 I 1 ·775 i .100 r-I .635 I I .537 I , : f-:~-:----:-"""""'; 
Double Support (sec) L-l:+ .693 (31). /43·'!.l __ 1 __ .1 .563 I !~ _ _ -+_ .575 L I .600 /--1- .650 ' __ I
I%GC r R I .631 (29)/43.4T I .601 ' 1 .5S9 I-~ 1.0S0 I r-- .575 , .638 I I I 
I----::Ste~p':""Le-n-::gth:-(:-em-:)-;I·-_'7""~.926 (3) 1 _ __ 1_ L_~.~.:.:.~J I 49.785 ~ 46.603 1. ___ ' 48.227 1 __ .. 1_ 46.901 1 ___ 1 i R 1 21 .961 (13) r 19.m] I 25.';10 I I 20.613 1 I 25.452 1 1 21 .542l 1 19.473 i I------!--~~~~~ 
Stride Length (em) I L I 70.391 (5) ! I -jl 67.414 i I 75.190J_~67217 1· L 73.684 \' I 68.444 L-J 
1-____ ......,....;1 R I 70.556 (4) I I I 73.653 1 70.615 I 72.231 1 69.783 1 I 66531 : 
Base of Support (em) 1 L 1 13.47 (10) 1. __ 1 1 12.965 I ! 12.850 1----1~--J 12.397 I I 15.912 ! ' 
I R I 13.00 (17) I 14.351 I 10.399 I 15.672 I 1 11 .129 I I 13.428 I 
Toe In lOut (deg) I L I 4(61) I 1 I 3 1' -1 3 1 i 0 I 1 5 1 L-.-?J . 
iRl--~I-~ 13 I 12 l--"'l 11 1 I 13 1 1--;3j 1--1 
,------- -12st trial , lift R 
I L ____ _ 
-.,--____ .J 
UND 
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Tested on: 6/28/2007 '10:51 :47 AM ~--~~.~-=~~""! 
~~g_~~l~~~~~{ 
501 N Columbia Rd 
P. O. Box 9037 
Tel# 7017772831 '~--------l ~~~. (,'\ \ I Grand Forks NO 58203'=~=~Q. ~~ ~=_~ ! Age Gen;;;;r Let! LEG ~i9ht Weight ! 
t75~. ~~~..2.~ L~-=-~ ~'l~~ 
I " 
Functional Ambulafion Profile: 48 
,.=~~ =~==-':=':~ ~SJMi~r[E~l ~ Step Time Differential (sec~.... .37 ! =~~ __ .. ~ 1 (?.rTl~ ' Cycle Time Differential (sec) ,01 ~~==-~,~~~~-~~.~-=~~~===-~ 
- Mean(%CV) !---;"i1!--;'i2I-mI---:;'j,j"1 115 I 1/6 I -Walk#1 Footfall # I UR ! 1fT I 1/8 
Step Time (sec) L~J __ 1.021 (4) L __ .L __ L~~_I~ 1 __ L2.~ .L __ i 
I R I .556 (2) I I .637 I I .652 l .652 I I .552 ! 
Cycle Time (sec) L.::-I 1.675(3) I 1 __ ~1_~_1.675 1_ I 1.725 i ' 
i Rl 1.683 (2) I I 1.650 I 1.675 I 11.725; 
SWing Time (sec) L.::-l 
.61 3 (9) 136.6 !----l---l-~L--L~L---1~---! 
I%GC ! R I ADO (3) 123.8 I I I AOa I : .412 I I .337 : 
Stance (sec) I L L 1.052 (3) 163.4 I~_ L~.:~;_.--J~ __ I ___ L-.J 
1 %GC [Ri 1.28«4) .'76.3 I 1250 I I 1.263 I i 1.338 I I 
Single Support (sec) L~I~~~)123.9 J- __ I~- 4OOJ ___ I~ !.~ ___ ~ 
I %GC I R I .613(3}/364 I I .550 f 1 .650 I I .636 I , . i 
Double Support (sec) I- .!=..I .654 (4) 139.0 I . .-I _ __ l_~~ __ ~~-1-_J .663 I ! 
I%GC r. 1 .671 (8) /39.9 , , .701 I ! .613 I . 70~ I ! 
Step Length (cm) I~I 51.743 (2) J I ! 523~_1~_ 52.055 1 __ ~ __ 50.822...1 ___ [ 
23.955 (11) I , 23.634 I 20.474 25.379 I 20.354 ! 
Stride Length (cm) I_~-L_ 76.910 (2) I_~I __ .J. 75.938 , I 78.543 ' ~ 76.200 I i 
R 1 75.052 (5) 1 , 1 I 78.829 I ___ i 77.447 ___ 71.279 ; 
Base of Support (cm) ~I 12.19 (9) I --1---1~~' 11 .129 1 ! 13.268 '--1 
R I· 11 . /8 (S) I 12.437 I 11 . 154 ! 11.747 I ! i 
Toe In 1 Out (deg) ~. ___ 2_ (34) 1----l---I~ 
. R 14 (5) I 13 I 13 1 ~-~ 1 I I 
r4th trial , no lift 
i 
I 
i 
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Testedon: 6/28/200712 :07:'14 PM 
UND 
501 N Columbia Rd rel# 7017772831 
p, 0, Box 9037 
Grand Forks NO 58203 
rA~e~G:;;;;",r'~ Left LEG"Fit;;; I H:J;i,t·V .. ;;;;~ht =1 
l!2.v=r.!~1~~ __ ",,=~~~.~2:L!!....~w.g,. ___ .~~.! 
-
---- 1/6 1---:u71---;;s'i Walk # 1 Footfall # I UR i Mean(%CV) I 1/1 ! 112 ! 1/3 ! 1/4 I 115 I 
Step Time (sec) '~~.0=8:10) I __ L-.J~':~.L ___ j_....:975 L ____ ~~L-: 
I R I ., 5. (7) I 1 ·775 I I .6c: I . 81~ I I . 75~ ' 
Cycle Time (sec) ! L 1 1.817(9)+ __ 1 ___  1._1.800 J ___ I_ 1.662 L ___ 1_ 1.988 J ___ I
IRi 1.806 (6) I I 1 1.712 I I 1.788 I i 1.925 : 
SWing Time (sec) :~J .64~_~__ ! __  L .653 L--I-~~-L---l~-.--: 
I%GC I R I 45~ (7)125.1 ~ I 1 425 I I 486 I I . ~50 I 
Stance (sec) I L i 1.175 (12) 164.7 I 1.137 I I 1.00"'2 1 -.J 1.325 I I 1 __ 1 
I%Gc j R ! 1.354 (il) 174.9 i ! 1.287 I 1.300 I I 1.475 I I I 
Single Support (sec) h L I .454 (7)/25.~ _ _ I ___ ~1 , .488~~ ___ 1 
I%GC . R ! .642 (6) 135.5 I I .063 I ! .6c:J I i .653 I I 
Double Support (sec)! L '. 737 (14) 140.0 I 
I%GC ,-·Rf.m (13)/39.4 I 
~.I~J __ -L~E..J _ _ !-E~L __ ! 
. .624 1 I .700 I ! .B13 I I : 
Step Lenlt.h (em) I Li 49.005 (4) 1 I I~ I 48.732 1 I 51.041 1---1 p. 1 I -- ---;;-----~t .--. I 43.804 (l a) I 41.405 36.8__ ! I ,8 .. 2" I 46.60J3 ! 
Stride Length (em) l--M- 91 . 6~<z2.J ___ L~~~_L_~·600 I ___ J~..I __ : 
, R I 93.647 (7) I I I I 85.109 I "I 96.978 I I 97 . El~4 ' 
Base of Support (em) L_L I 183~ __ 1 I 16.956 h-~I---I- 17.979 1 ___ -.: i R 18.44 (0) I 19.781 I 'j 5.973 I 16.554 I I 
Toe In 1 Out (deg) 1_~1 ___ 6 (44) I---I---i- 7 i __ ~I---1 8 1 1 
I R 13 (11) I 15 ~ 13 12 I I 
2 trial, lift 3/8 
L ________________ _ 
UND 
501 N Columbia Rd 
P. O. Box 9037 
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Tested on: 6/28/2007 11 :56:44 AfVl 
Te/# 7017772831 
Grand Forks NO 58203 
l£f:~er 1 8~eft=LE~jtt. ~:ht 0 
Parameters 
Distance (cm) 286.0 
~---=--~===-~~~~~~=T~~~~~ Ambulation Time (sec) 6.35 
Functional Ambulation Profile: 58 
~=_~===_ ::-- Cadence (~in) r~ 
Step Time Differential (sec) .26 ~ 
Velocity (cm/sec) 45.0 ~~= SteE..,Length Differential (cm) '~=l 
Cycle Time Differential (sec) .03 
~~~,==~=--~~.=~ -= -
Mean NormalizeciVelocity .57 
~~====~===--~-=-=.~===-========~~~=-~~~ 
Walk#/Footfall#i"URI Mean(%CV) r---;n-I---u2I--m'"1 1/4 I 1/5 1--v6'1-w'",---va. 
Step Time (sec) L L 1 __ ~054(~Jj_._I_-1~---1 .0121---I---;:m-I~ 
1"Rl .797(s)j .650 ,-1 .1/5 I .613 1 .750 I--__ ~--: 
Cycle Time (sec) I L I 1.667(4) I I j 1.888 I ___ J~ __ J 1.925 ! 
I R I 1.833 (1) I 1 l~ 1.613 \ 1.825 -I 1 1.852 i I----::.....,...~.......,...-: 
SWing Time (sec) 1_~1----,629 (5) 1332..J L_ 1 .600 1~_.625 1 ___ ~~1 ___ 1 
I'l6GC , RI.417 (2) 122.7 ~r-- I l--:4i3f .413 1- 1 A25 ! 
Stance (sec) 1_ ,=-L !·23~ (5) 166 ~'---22~~L ____ L~-' I 1.263 L- m _-' __ --1 ___ . 
1-___ ...;./..;,;:'l6..:..GC:...:iRJ1.416 (1)m3 I -r-1AOO I ~ 1.412 I 11A37l I ! 
Single Support (sec) 1--'=-1 .417 (2)122.3 1--1 I .413 1 I .41 3 1 I .425 1 ' 
1 'l6GC R l .629 (5) 134.3 I I .600 I .625 I .652 1 I 
Double Support (sec) I_L 1~(10) /41 . 1 I I I _ .749 I 1-----'--~1J~ .700 I I 
I'l6GC R .787 (2) 142.9 I .800 1 I .767 ~ I I 1---.....,...-,--: 
Step Length (em) L. L _I 43.299 (6) , I I 43.273 I I 40.852 I I 45.762 1 I 
iR 39.015 (10) I 34.357 I 40.272 I 37.555 I 43Ac5 r 
Stride Length (em) I L I 80.856 (4) I ___ ,_L I 77.667 I I 81.135 I J 83.746 1 I 
I R i 83.872 (6) I- I ~ I 63.559 I I 75.818 -] 89.229l 
1-:::---:-:.....,...--:-:-_: 
BaseotSupport(cm) I LI 18.34 (7) 1----' 1 17.804 1 1 17.485 1 119.721 I 
I R 17.77 (5) ~17.471l---1 17.01€ 1 18.809 •. 
Toe In lOut (deg) I R LL I 6(1 7) I I 1---2J 1 ____ ~ .. L---1 __ 6.J __ _ 
IRl 12 (12) i 14 l--,-:;-j I 12 I I : 
r rial, no lift in shoe now 
I ee. 
UND 
501 N Columbia Rd 
P. O. Box 9037 
75 
Tested on: 6/2812007 1 :30: 17 PM 
Tef#. 7017772831 
Grand Forks NO 58203 
~"ge'-Ge~der I -"[;;f"7£GRi;i;/'i
1 
;==weight l 
~_~.l~_=.~~~~~oJ 
... 
-
.. •• 
I~~-'~~~'~--'" , 1-------L----1 
f=-~~-~ 
Walk #1 Footfall # i~! Mean(%CV) '----v1t----m-I--mI--mI--vsI--vsI--wI~I__v9i--moI--;mI1i12i-1;;3! 
Step TIme (sec) I_ L 1_~96 (11) ~-+-!~ I A75 ! I .437 ~~ 1----:s12l---I~ 
R 1 ,702 (12) I ,788 1--"1 ,7',2 r-I , G~3 i 1 ,536 I~ ,663 I I ,800 I i 
t--c::-YC-:le-:TI=-,m-e-:(s-ec-:)-:i-==L I __ 1,192(7)J __ J ___ I~~~1 I 1,187 1 I 1,050 ~l~I __ J~L __ 1 1,250 i 
1 R I Ue5 (9) 1 I r--l 1.237 1 I 1,085 1 1,025 I I 1,250 1 I 1,:;12 I i 1---------1 
Swing TIme (sec) I L I ,325 (7) 127,3 I I I ,338 I ~ I ,300 ~I ,325 1 I~.--l ,300 ! 
I%GC i~ .453(18)/39,1 I T I I AS7 I 1 .412 I 1-----:3031 1 .413 r- ---j ,608 1---! 
Stance (sec) I L 1 ,8S7 (10)1727 1~ __ I _~ I~--.-l ,850 I I~ I~I ___ I--J 
I%GCl RI ,,23(9)/61 ,0 I-I ,750 I~ I ,6G2 1 ,537 1 I~ I ,700 ' ; 
Single Suppcrt (sec) I~ A63(18)/38.1~_L_J __ ---.J ,437 1 I .413 i ~ _ __ !~I __ , I ,600 I ',500 i 
1 %GC I R I ,325 (7) 127.4 ! ~ :;381~ ,325 I I ,300 r~1 ,325 1 1 3521 I ,3OJ 1 i 
Double Support (sec) !_ L I ,396(14)/33,2 1 ___ L I~I I ,338 I !~. I ADO 1_ ! ,350 I T A25 I 
I%GC R ~16j1336 I ! ---:412l I ,350 I I ,352 I I ,512 1 ,350 I I~1-------; 
Step Length (cm) I L I 35,407 (6) I I j 35,565 I I~_~ 37,399 I II Z5,919 I .-I 34,679 J : 31,854 I 
[R 19,906 (6) : I 17,985 1 ~ ! 199'631 ! 19,749 , 19,931 1 121.4091 I 
Stride Length (cm) I L 1 55A87 (4) 1---.-1 I 53,556 1 I 58A20 1 ___ 1 57,363 J_ 1 55,670 1 ___ 1. 54,612 1 ' 53,299 
1 R 1 55.650 (4) I~ 1 I 56.9.7 I ! 56,994 I 57 mj I 55,851 56,089 I I 1------: 
6aseofSuppcrt(cm) I_ L 1 __ ~~--1_ I' 11 ,293 1 ___ ~736 I l~ I 11 014 1 I~~. ___ I 12,282 
I R I 11 .43 (7) I I 11 ,932 I 10.313 1 ___ 1 ~1 ,275 I_-_I_~___ I 11 ,050 , ___ 1 12.459 ' ___ I 
Toe In lOut (deg) I . L I 2 (55) !---l_ I 1 1 I 3 I !~ , 1 I I 31 I 1 I 
1RI 10 (11) I I 1cil----'!~ I 11 I I 10 I 11 I 11 I 
12 trial, no lift 
~------------------
76 
Tested on: 5/28/2007 1 :37:33 PIVI ~~ UND 501 N Columbia Rd 
P. O. Box 9037 
Grand Forks NO 58203 r~ h l1h=2:~ 
Tel# 7017772831 
Su.'o-e t 3 ] 
~~=~w~~~m . ' ==t _~=.l~~~~l 
Walk # 1 Footfall # ('URI Mean(%CY) ,----m-,--v2(-'''v3'r -1i4'''-"'1i5'-'1i6r '''1'i7j-va'-mj-mD11i1'1j -W'--:;'i13i 
Step Time (sec) I L I .473 (4) I , j .488 1 1 .462 1 I .438 1 I .467 1--1_ 0487 I I~: RI .677 (6) , I .652 r--r~--I--625-1 ! .750 I .713 1 I~ ! 
Cycle Time (sec) 1-*-1 1.152(5) l--l __ l---':~I I 1.137 1 I 1.063-j I 1 . 237 ~ I~J 1 1.125 ' I 
R I 1.152 (4j ! I ! 1.163 I ' 1.051 r'- 1.188 I ~ . 200 I 1 1 137 1 
Swing Time (sec) I~ .319 (6) 127.7 I 1 I . 3~~~~1 I .288 I 
.525 1 
.~ . I . 337~~ 
1 %GC R .465 (12) 140A I I 1 .357 I I I .513 I I .450 i 
Stance (sec) I L L .833 (5) 172.3 I . 82~ ~1 I~L--' .900 I 
.687 1 
.863 I 
--L .813 i I ' 
I%Gc jR-j .688(3)/59.7 1 I .675 ~ I .653 i 1 1 .587 I , .713 j---i 
Single Support (sec) ~I .465 (12) 140.4 1 1 M-·-+-~_---.J .525 I _I~~~i I .425 I%GC R r .319(6)/27.7 I I .325 .312 1 .2eS I 1 .337 .337 I I .312 1 ! 
Double Support (sec) !_~ 
.372 (7) 132.3 1 ~I~ ._~! __ I .376 1--'_ .351 1 __ M I .413 I 
I'lOGCI RI .369 (o) 132.0 .351 i---I .388 I 1 .275 ~ Z50 I ~ .350 I 0401 I 1 
Step Length (em) I_ L I 35.211 (5) I '- I __ L 33.380 I I 34.585 i -.-l 33.453 I I 35.763 L-I 37.242 1--' 36.845 ' 
1 RI 18A31 (11) I l 17.215 ! ~ 18.199 I 1 17.261 I I 22.586 i I 19.632 I I 17.557 1---; 
Stride Length (em) , L I 53.958 (6) I I I 50.595 1 i~I _ _ l 50.733 I I 58.360 '--M --1 54.403 I 
1 RI 03.854 (3) I I 51 .596 I 1 51 .846 I I 56050 ! I 55.396 I 54.8')5 1 
Base of Support (em) I L I 1154£U J --, 12.615 I_ I 12.~_1 100434 '-_ I 10.928 L_~ 11 .356 I_I 11 .524 i 
I 1< 1 11 .74 (8) I 1 13.253 ! I 12.W I 11 .695 I I 10A32 I I 10.895 1 I 12.001 1 ! 
Toe In lOut (deg) I L ' 3 (97) I H --2J ! 2 1--' 1 I , 6 1 9 1 4 1--' -1 I RI ~O (11) , . 10 ,- 1 10 1 , 12 , I 10 I , 9 ,----' 
2 trial, heel lift 
UJ~JD 
501 N Columbia Rd 
P. O. Box 9037 
77 
Tested on: 7/11 /2007 1 :39: 03 PM 
Te/# 7017772831 
Grand Forks NO 58203,r~~_.~~=_~~_.~~ -~~~--'1 
flt.:!!:l:!.~G Ri~:~~(~:~ .. ~:~~ .~J 
Walk#1 Footfall # ('i:jR1 Mean(%CV) 1--m1----m-I--m!---v.;-I-1i5r-1i6!--wI---vBI--mr-1i1or-1ii1r-17i2I~ 
Step Time (sec) ! L I .393(7) I 1_ .400_ 1. __ ._I __ .4~L-i~1 _~ 388J -' .38B I ___ !_~~  ___ : 
I R. ,,15 (9) 1 'I 1 655 I 1 1.075 ! 1S75 ! ~ r--! .767 1 i .912 I 1-----,-...,..,----,----1 
Cycle Time (sec) ! L 1 1.3OB (5) 1 .I---.-J---.-J~ ___ !~ 1 ___ 1_2:.~.~.J--.J~1 ___ 1~ _ _ _ ' 
I---:~"""'---:----II ;< I 1.308 (7) 1 ! !~ ___ ! 1.475 ! ___ l 1.237 . ___ 1 1:;'75 I_~ _~! ___ I~
SWingTime(sec) I_L U~(11)/12. B L_~ I ~!--~ L ! .175 i I~'-_i~----l 
1 %GC 1 P. I .623 (19) 143.0 1 I I .550 I I .853 I i .6"521 I .5001 1 487 I i .600 
Stance (sec) I L I 1.141 (7) IB7.2 I _ __ I~ ___ I_ 1.300 L_I~~I 1.112 1 1 1.062 1 !~I ___ . 
I %GC IR1 .680 (11) 152.0 1----:7s8j 1 .525 ! I .575 1 I .775 i I .685 I I 750 i I .675 I 
Single Support (sec) i~ .628(19)/48.0 I ! .550 i I .850 .1 ___ 1 __ .662 ' ___ 1_ .500 ! I~ __ i~~: 
I%GC l RI ·167(11)/1:L:! 1 1 i .200 1 1371 ~ .175 1 ~I \ i63 \ 1.163: 1--------1 
Double Support (sec) I L I .513 (14) 139.2_H~ __ ---L~---1~L __ ~J 1 57~ ___ 1 .562 1 __ _ 
I%GC R 1 .~1 3 (11;) /39.2 I I .425 I ! .4~S ! I .600 1 I .526 1-' .587 I~ .513 I 
Step Length (cm) I LI -1.480(>1 00) H 2.070 i I .621 1---1 -1.521 L I -6.180 1_-' 5.784 _L- i ·4.949 1=== 
1-_____ -:I.--=-.:R+! __ !.;,:.O .:::.20:.:G..:..(7)~. 1 1 4 1 . 22~ i /'0 .767 1 I ~') 158 1 I 39.582 I 1 36.653 1 1 35.3S4 
Stride Length (cm) !~L 38.408(11) I 1 _ __ 1 ___ 1 42.617 1~ 36.301 i ___ 1 36.222 1 ___ 1 45.633 ~..J 31 .719 1-, 
1 R 1 33907(12) ! 1 44.0:14 I~-I 1 27.m I~ 33.500 I ~l 1 30.776 ! 
8ase of Support (cm) f--.:!:-! 21.15(12) ! 1-.29.657 ! I 22.493 1-----.J 24 . 122~ I 20.002 1_ ! 24.285 1 I 20.307 \ : 
I R I 21.05(11) I !~ 124325! -1 20.822 I ! 232213 1 I 22.994 ---17.552l 
1---:,.--,------,-,..--
Toe In/Out(deg) W! 27 (7) I ~IH. __ 2_8 I __ I_~I__ I 2., t.--l_.E...! I 23 1 I 
I R 1 -7 (>100) I -4 I -7 I ! -ei~ -9 1 i -11 I I -2 i 
78 
Testedon: 7/11 /20071 :33:26 pr\~ ~ UND 
501 N Columbia Rd 
P. O. Box 9037 
------~~~.M=-·--~~~i 9 I 
Tel# 7017772831 
L~Grand Forks ND 58203.F"_~~~~~":""""o"~"-=~~ Left LEG Right -I Height Weight 106 106 0 0 ~--~~--=====-~-===~~ 
Functional Ambulation Profile: 45 
~- Cadence (StePsiMfn) 89.4 
Ambulation Time (sec) 11 A 1 Step Time Differential (sec) .56 
~~·~~=V~el~o'""ci"'"'ty~(~c-m-;/s=e=c~) +-27.1 
- Step L ength Differential (cm) 48.65 
Mean Normalized Velocity .26 ~CyC!e Time Differe ntia l (~se-c~)+-~.O~O--
~~ - = ~= = ...... ~ 
Walk # I Footfall # j'URI -- 1/5 I 1/6 1---w""1 1/8 I 1/9 1-mD1--v111 Mean(%CV) I~ 112 I 1/3 I 1/4 I 1/12 I 1113 
step Time (sec) I-+l 
.407(1 1) '--!_ .437 1_ I~ __ ~~- I~ 1 .425 1 I .362 1 I 
RI .969 (10) 1 1 I -:9i3l r .950 1 .952] 952 I ! 1.065 1 I .988 i 
Cycle Time (sec) 1 L f 1.372 (5) 1 1 
-i h~ 1.363 1 ~~~ 1.367 I 1 1.450 I , jR 1.372 (10) 1 I 135:J 1 1.362 I 1.375 1 1 1.400 1 1.513 1 1.350 i 
Swing Time (sec) I-+l .183 (12) 113.3 1--1_, I 1 .200 I I .168 1-----1 .200 1 1 .200 1 ~ I 
I%GC R .653 (14) 147.6 I I .585 1 I .625 1 ! .662 1 .575 ~---:813 1- .613 i 
Stance (sec) I L l 1 . 189(6)/86 .7 1-l~h_I~!--m1 1.200 I ~I I~ __ -l 1.225 1 i I%GC Rl .719 (13) 152.4 I .762 I .737 I .713 .825 I .700 I .737 1 1 .775 I 
Single Suppcrt (sec) 1 L 1 .653 (14) 147.6 I I~ I .625 '--L .862 I 1 .575 1 .2Qo I .813 1 1 .613 1 I%GC R 1 .183 (12) 113.3 1 .20;) 1 1 .188 1 I .200 I .162 I 1 .20D 
Double Support (sec) 1 L 1 .536 (10) 139.1 1 r- 536 i I .550 1 __ I~-----1 .612 I 1~ ___ I~___ i, I%GCI R I .538 (16) 139.2 I .537 I 1 .525 j 625 I I .500 I .575 ! 1 .575 I 
stePLength(em)l~ .4.732(>100) 1-1 .6027_1-1~I~ -7.562 1--.l~~ -19.633 1 
42.557 1 
-~221 1 ___ , 
I R 1 43.915 (17) 1 38.955 I 41.795 1 33.626 1 1 61 .642 1 39876 
Stride Length (em) 1 __ ~+ __ r ·580 (12) 1 ---1---'~ 45.377 1 1 34.253 1-1 42.359 I I 42.021 1 I 40.371 I I 
R 39.974 (31) I 32.932 1 48.284 I 31 .255 I I 65.344 I 25.000 I 1 37.818 : 
Base ot Support (em) 1 L I 20.93 (15) I 1 22.353 I~ 20.999 I 1 18.551 1 I 24.254 1 I~ ~ 19.387 1 I 
R I 19.124 I I 19.970 1 26.638 1 1- 16.910 i 18.607 2D.88 (16) 1 22.444 1~ I 
Toe In lOut (deg) 1 L I 28 (34) 1 1 26
1 -2 1 
25
1 
1 32
1 
1 ~ 0 1 7 I i ____ 33_! I I R I -9 (>100) I I -3 ! -10 I I~ ~. 
\-\te. \ 
Testedon: 7/11 /2007 2:38:23 PM 79 
Tel# 7017772831 
Walk # I Footfall # ('URI Mean(%CV) 1-1i1Y--v2I-m, -1/4 I 1/5 I 1/6 : 
Step Time (sec) I_ L I .556 (2) I ! ! .550 1 I~ ~ 
it , .517 (5) I -r-A87-I --~ - .525 i 
Cycle Time (sec) I_ L 1 1069(4) ~I j 1 .037~ 1.100 I : 
! R 1.08& (0) I I , .osa I - 1.037 ' 
Swing Time (sec) L LJ .331(8)/31 .0 ~~~ 
.388 1 
.350 '-_I 
I%GC I R! .375 (5) 13A .5 I I .352 : 
Stance (sec) L.!:..I .738 (2) 169.0 j . 725 I---::.:-:.J~  _ _ ~1 
I%GC I R I .713 (2) 165.5 1 I .700 I .725 . i 
Single Support (sec) I L I .375 (5) 135.1 I I~ 
.
388
1 I .362 I ! 
I%GC I R I .331 (8) 130.4 ~I .312 .350 I I , I 
Double Support (sec) I- L I .375 (5) 135.1 L r-~388 1 .362 ;--1~ __ ' I%GC R 1 .352 (2: /35.1 1 I .375 1 I i 
Step Length (cm) ~I 66.244 ~1) I I I 66.696 J 54.281 I 65.791 I R I 50.095 (8) 1 45.451 1 1 49.552 : 
Stride Length (cm) I LI 117.313(3) ~D114.439 1 1 , 20.187 I ' 
1 R I 11 8.845 (4) 1 - . 1 ,22.290 I ! 115.400 
--------------------Base of Support (cm) 1~~~ ___ I---1 11 .753 I 
5.437 1 
9.868 1 I 
it 1 8.78(54) I I 12.115 I 1 1- [ 
Toe In / Ou1 (deg) I ~ I 9~ I T 9 l _ _ BJ I I 1 (>100) I S I I -2 1 r--: 
no lift 
UND 
501 N Columbia Rd 
P. O. Box 9037 
80 
Testedon: 7/11 /2007 2:32 :13 PM 
Tel# 7017772831 
Grand Forks NO 58203 
~;; Gender D eft LEG 'R;h~m'W~ighl -
74 ~~_OO ___ ~d 
•• .-
Functional Ambulation Profile: 79 
~~=~dence ~PS/Min) ' -1 02.0J 
t Step Time Differential (sec) .00 ' =, Mean Normalized Velocity .91 J -_=~~srep L~~erential (cm) 1s~~ Cycle Time Differential (sec) ' .03 ~~.....:=J.~=u.;r=--~~l'~ ~ ~~~ ~~~ .. ~~~ .~==~ _~"=~:!I.::.=r-
Walk #1 Footfall # I UR I Mean(%CV) I 1/1 I 112 1-v.31-m1--VSI---:;;sr-1i7~ 
Step Time (sec) ~ .587 (4) I .612 I 1 .575 L-l~I __ _ , I 
R I .58a (6) ! 1 .550 1 1 .600 1 I .613 : 
Cycle Time (sec) G 1.150 (3) I I 1 1 .1~ __ -:-~~~L--, R --i1750l 1 1.162 I I 1.1h 1 1.16S , 1 
Swing Time (sec) Ri .356 (17) /31 .0 I I I .312 I 1 .400 L--J I 
I%GC R .400 (8) /34 .0 I I . 382 1~ .425 1 1 .413 ! 
Stance (sec) I~ .794 (3) /69.0 1 ! .813 I 1 .775 1 1 --l I 
I%Gcl R 1 775 (3) /65 0 I .800 I 1 75Ol---i-ns T 1--- ' 
Single Support (sec) I L I .400 (8)/34.8 I ~~h I .425 I i~ ! 
I%GC R I .355 (17) /30.3 I ! .312 I 1 .4Da I r~ 
Double Support (sec) I L I .409 (13) 135.6 I L~ I .350 I I 
.4
26
1 I 
I%GC R I 0405 (1 1) /34.6 I I .438 1 i .375 I I 
Step Length (em) I_ L 1 64.461 (5) I I 63.490 I I 67.767 I I 82.125 1 I 
I R 49.00J (12) I 1 I 42.326 I -I 53.881 j- 50.793 I I 
Stride Length (em) ~ 113.105(4) 1 1--1 1 110.127 ~ 116.082 ~: 
113.499 (7) 1 1 f 105.633 I 1 121 .601 - -- 112.998 : 
Base of Support (em) ~ 9.66(17) '---I 8.718 1 I 11.614 I ~~ _ __ I 
R r--9.83 (1 8)l 11 .140 1 1 8.627 I i i 
Toe In lOut (deg) I L 1 11 (16) I ! 12 1 ~ 9 1 1 12 I i 
I RI ·1 (>1 00) I I~- -4 --J ::l/ r--
lift 
APPENDIX F 
DVD is attached to the back cover. 
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